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ABSTRACT 
 
Background 
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in 
the U.S. Acute myocardial infarction (AMI), with or without ST-segment elevation, is a 
common presentation of coronary heart disease and affected more than 800,000 
American adults in 2010. The overall goal of this dissertation was to examine decade-
long trends in the extent of delay in the receipt of a primary percutaneous coronary 
intervention (PCI) among patients hospitalized with ST-segment elevation myocardial 
infarction (STEMI), 30-day hospital readmission rates in patients having survived an 
AMI, and multiple decade long trends in 1-year post-hospital all-cause mortality, as well 
as factors associated with these outcomes, among patients hospitalized with AMI.  
Methods 
Data from the Worcester Heart Attack Study, a population-based chronic disease 
surveillance project that has been carried out among adult residents of the Worcester, 
MA, metropolitan area, hospitalized with AMI on a biennial basis from 1975 through 
2009 at all medical centers in central MA, were used for this dissertation. 
Results 
Between 1999 and 2009, among patients hospitalized with STEMI, the likelihood of 
receiving a primary PCI within 90 minutes after emergency department arrival increased 
dramatically from 1999/2001 (11.6%) to 2007/2009 (70.5%). Between 1999 and 2009, 
among hospital survivors of an AMI, the 30-day all-cause rehospitalization rates 
   
 
  
decreased from 1999/2001 (20.3%) to 2007/2009 (16.7%). The overall cause-specific 30-
day rehospitalization rates due to CVD, non-CVD, and AMI were 10.1%, 7.1%, and 
1.8%, respectively, during the years under study. Between 1975 and 2009, among 
hospital survivors for a first AMI, the 1-year post-discharge mortality rates remained 
relatively stable from 1975-1984 (12.9%) to 1986-1997 (12.5%), but increased during 
1999-2009 (15.8%). We identified several demographic, clinical and in-hospital 
treatment factors associated with an increased risk of failing to receive a primary PCI 
within 90 minutes after emergency department arrival, 30-day readmissions, and 1-year 
post-discharge mortality.  
Conclusions 
Our findings can hopefully lead to the enhanced development of innovative, patient-
centered, intervention strategies which can further improve the treatment and transitions 
of care, as well as short and long-term prognosis, of men and women hospitalized with 
AMI. 
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1.1 Specific Aims  
Cardiovascular disease (CVD) remains the leading cause of morbidity and 
mortality in the United States.1 Acute myocardial infarction (AMI), with or without ST-
segment elevation, is a common presentation of coronary heart disease (CHD) and 
affected more than 800,000 American adults in 2010.1  
The prompt administration of coronary reperfusion therapy for patients with an 
evolving AMI is crucial in reducing mortality and the risk of serious clinical 
complications in these patients. In the past decade, primary percutaneous coronary 
intervention (PCI) has gradually replaced thrombolysis as the main revascularization 
strategy for most patients presenting with ST-segment elevation myocardial infarction 
(STEMI).2 Although clinical guidelines recommend that patients with STEMI receive a 
primary PCI within 90 minutes after hospital presentation,3 there are little population-
based data describing contemporary trends in the proportion of patients with STEMI who 
receive a primary PCI and the characteristics of those experiencing delay from hospital 
presentation to the initiation of a primary PCI.4–6  
Thirty-day hospital readmission rates have become a quality performance 
measure for patients hospitalized with AMI,7 and nearly 1 in 5 Medicare patients 
hospitalized with AMI are readmitted within 30 days of discharge.8 There is a great deal 
of interest from hospitals and clinicians to better understand and improve modifiable 
factors associated with 30-day hospital readmissions, which are increasingly being linked 
to hospital reimbursement.9 However, we have limited contemporary data that describe 
trends in 30-day readmission rates as well as demographic, clinical, and treatment related 
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factors associated with 30-day readmissions among patients surviving an AMI, 
particularly from a more generalizable population-based perspective. Finally, although 
several studies have reported improvements in long-term survival among patients after 
hospital discharge for AMI,10,11 there are little data describing post discharge death rates 
after a first AMI and changes over time therein. Moreover, scarce population-based data 
have characterized contemporary trends in long-term survival, and prognostic factors 
associated with long-term mortality, among patients who survived a first AMI. 
The overall goal of this dissertation was to examine the extent of delay in the 
receipt of a primary PCI, 30-day hospital readmission rates, and 1-year post-hospital all-
cause mortality, as well as factors associated with these outcomes, among patients 
hospitalized with AMI. These objectives were accomplished from the perspective of a 
population-based investigation among adult residents of the Worcester, MA, metropolitan 
area, hospitalized with AMI at all medical centers in central MA (Worcester Heart Attack 
Study: WHAS).12–15 The WHAS is an ongoing coronary disease surveillance project that 
has collected data about patient’s demographics, medical history, clinical and laboratory 
findings, receipt of cardiac treatments and revascularization procedures, and post-
discharge survival status over 3 decades (1975-2009). The WHAS offers a unique 
opportunity to study changing trends in patient characteristics and treatment practices, as 
well as short and long-term outcomes, in patients hospitalized with an independently 
confirmed AMI.    
The specific aims and accompanying hypotheses of this proposal were as follows: 
Aim 1: To examine decade long trends in the extent of delay from hospital emergency 
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department presentation to the initiation of a primary PCI over time, and associated factors, 
among patients hospitalized for STEMI in the WHAS on a biennial basis between 1999 and 2009. 
Hypothesis: Among patients hospitalized with STEMI who underwent a primary PCI, the 
proportion of patients receiving this intervention in a timely manner (≤90 minutes) after hospital 
emergency department arrival increased during the most recent compared with earlier study 
years. Older age, history of several comorbidities, and in-hospital factors were associated with a 
higher risk of prolonged delay in receiving a primary PCI among patients with STEMI.  
Aim 2: To examine decade long trends in 30-day readmission rates, and associated factors, 
among patients hospitalized for AMI in the WHAS between 1999 and 2009. 
Hypothesis: The 30-day readmission rates of patients discharged after AMI decreased during the 
most recent compared with earlier study years. Older age, history of several comorbidities, and 
development of in-hospital clinical complications were associated with a higher risk of 30-day 
readmission. 
Aim 3: To examine trends in long-term prognosis, and hospital treatment practices associated 
with post-hospital 1-year all-cause mortality rates, among patients who survived a first AMI in 
the WHAS from 1975 to 2009. 
Hypothesis: The 1-year all-cause mortality rates of patients discharged after a first AMI 
decreased during the most recent compared with earlier years. Hospital treatment practices were 
associated with improved survival during the first year after hospital discharge for an initial AMI. 
 
1.2 Background 
Acute myocardial infarction among U.S. adults 
Cardiovascular disease (CVD) remains the leading cause of morbidity and 
mortality in the United States.1 In 2010, CVD accounted for nearly one third (787,650) of 
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all deaths occurring in the U.S. Coronary heart disease (CHD) is the most common type 
of heart disease. It has been estimated that 15.4 million adult Americans have CHD 
(prevalence: 6.4%).1 Beginning in the early part of the 20th century, death rates from 
CHD in the U.S. increased dramatically reaching epidemic proportions by the mid to late 
1960's.16 Between 1968 and 2008, the death rate from CHD declined and there has been 
an approximate 5% average annual decline in the age-adjusted mortality from CHD in the 
U.S. between 1999 and 2008.17 However, CHD continues to be the major cause of 
mortality in American men and women. In 2010, CHD death rates (per 100, 000) were 
152 for white males, 169 for black males, 84 for white females, and 105 for black 
females.1  
Acute myocardial infarction (AMI) is the acute and life-threatening form of CHD 
that accounts for most CHD related hospitalizations. The two principal clinical 
manifestations of AMI based on serial ECG findings are ST-segment elevation 
myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction 
(NSTEMI). These disease entities share common pathophysiological origins related to 
coronary plaque progression, instability, or rupture with or without luminal thrombosis 
and vasospasm.1 In 2010, there were more than 800,000 hospital discharges for AMI 
(including primary and secondary discharge diagnoses).1 Approximately one third of 
patients with STEMI die within 24 hours of acute symptom onset, emphasizing the need 
for prompt and effective treatment.18 The 30-day all-cause hospital readmission rate is 
nearly 20% for Medicare patients hospitalized with AMI.8 There is  great interest in 
understanding and improving modifiable factors associated with 30-day readmission rates 
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due to ongoing and planned changes in reimbursement policies.9 Moreover, about 1 in 5 
men and 1 in 4 women may die within the first year after hospital discharge after a first 
AMI.1 Given present trends of an increasingly older patient population with a greater 
prevalence of comorbidities,11,19,20 the management of patients hospitalized with a first 
AMI presents significant challenges to health care providers.  
 
Aim 1: Delay in the receipt of a primary PCI in patients hospitalized with STEMI 
The prompt seeking of medical care after the onset of symptoms suggestive of 
AMI has been associated with the receipt of coronary reperfusion therapy and effective 
cardiac medications in hospitalized patients. Timely medical care is crucial to reducing 
mortality and the risk of serious clinical complications in patients with AMI, since it can 
maximize benefits of evidence-based treatments, and possibly reduce sudden cardiac 
deaths and the eventual size of the infarct. Early administration of coronary reperfusion 
therapy improves survival in patients hospitalized with STEMI by reestablishing 
coronary blood flow within the occluded infarct-related artery.21 In the past decade, 
clinical guidelines have emphasized the importance of rapid reperfusion of patients with 
STEMI and specify a maximum delay of 30 minutes for the use of fibrinolytic therapy 
and 90 minutes for  administration of a primary PCI in these patients.3 Reperfusion 
therapy administered beyond guideline-recommend times has been associated with 
significantly increased 30-day death rates.22 In contrast, among patients with AMI 
without ST-segment elevation (NSTEMI), the culprit artery is often patent and the patient 
typically has a good response to initial medical treatment.23 Among initially stabilized 
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patients with NSTEMI for whom an early invasive strategy of coronary angiography is 
chosen, optimal timing of angiography has not been well defined.24 It is thus important 
that AMI patients are diagnosed rapidly for early risk stratification to assign appropriate 
treatments and improve their in-hospital and more long-term outcomes.3,24  
In the past decade, primary PCI has gradually replaced fibrinolytic therapy as the 
main revascularization strategy for many patients presenting with STEMI,2 since primary 
PCI has been found to be superior to fibrinolytic therapy when performed rapidly by 
expert teams.2 Data from the National Hospital Discharge Survey (NHDS) examined 
hospitalizations with a first-listed diagnosis of AMI over the period 1979 to 2005 and 
showed that PCI  was performed in 2.9% of cases from 1985-1987 and increased to 30% 
by 2003-2005.20 Data from the Register of Information and Knowledge about Swedish 
Heart Intensive Care Admission (RIKS-HIA) examined 61,238 patients with a first-time 
diagnosis of STEMI between 1996 and 2007; the use of primary PCI increased from 12%  
in 1996 to 61% in 2007 (p<.001).25 
Although primary PCI has been shown to improve outcomes in patients with 
STEMI, its effectiveness may be limited by delays in its more timely delivery.3 Data from 
the National Registry of Myocardial Infarction (NRMI) has demonstrated a strong 
relationship between door-to-balloon time and in-hospital mortality among 29,222 
patients with STEMI; after multivariable adjustment for several patient characteristics, 
each 15-minute reduction in door-to-balloon time from 150 to less than 90 minutes was 
associated with 6.3 fewer deaths per 1,000 treated patients.26 Currently available data, 
however, have shown mixed results of improvement in door-to-balloon times. Data from 
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the NRMI study examined patients admitted with STEMI who received a primary PCI 
(n=33,647) between 1999 and 2002; only 35% of patients were treated within the 
recommended 90 minutes after arrival at the hospital. Meaningful improvements in these 
times to reperfusion over the 4-year study period were not observed.5 Findings  from the 
Blue Cross Blue Shield of Michigan Cardiovascular Consortium of 8,771 patients with 
STEMI who underwent a primary PCI between 2003 and  2008 showed that the median 
door-to-balloon time had decreased annually from 113 minutes in 2003 to 76 minutes in 
2008 (p<.001). In addition, the percentage of patients revascularized with a door-to-
balloon time of less than 90 minutes significantly increased from 29% to 67% over this 
period (p<.001).6 
Although several studies have reported increasing use of primary PCI20,25 over 
time, there have been mixed findings in the extent of delay in receiving a primary PCI 
among patients hospitalized with STEMI,4–6 and only limited population-based studies 
have examined potential risk factors5,6,27,28 for delay in receiving a primary PCI using 
multivariable regression analyses. Inasmuch, there are few contemporary data that 
describe long-term trends in the extent of delay from hospital presentation to initiation of 
a primary PCI, and factors, such as patient demographics, history of comorbid conditions, 
and in-hospital factors, associated with the failure to receive a primary PCI within the 
guideline-recommended time frame among patients with STEMI, particularly from a 
population-based perspective.  
In my first study aim, relatively contemporary data from the WHAS,12–15  were 
used to examine possible trends in the extent of delay from hospital presentation to 
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initiation of a primary PCI over time (1999-2009), and factors associated with failure to 
receive a primary PCI within the guideline-recommended time frame, among patients 
hospitalized with STEMI at the 3 PCI capable hospitals in central MA on a biennial basis 
between 1999 and 2009. 
 
Aim 2: Thirty-day hospital readmission rates among patients who survived 
hospitalization for AMI 
Reducing hospital readmission rates is a national priority, as hospital readmission 
rates have become an indicator of poor health care quality and efficiency.29 Nearly one 
fifth of the 11,855,702 Medicare beneficiaries who had been discharged for any condition 
from a hospital were rehospitalized within 30 days in 2003-2004.30 The Patient Protection 
Affordable Care Act of 2010 has created new incentives to reduce readmissions because 
hospitals with high readmission rates can lose ≤3% of their Medicare reimbursement by 
2015.9 There is a great deal of interest from hospitals and clinicians to better understand 
and improve modifiable factors associated with 30-day readmission rates due to ongoing 
and planned changes in these reimbursement policies.9 
With advances in medical treatment, in-hospital survival after AMI has 
dramatically improved.20 Thus, many AMI survivors are being discharged from the 
hospital into the community who are at risk for hospital readmission. Approximately 20% 
of Medicare fee-for-service beneficiaries were readmitted for all causes within 30 days of 
discharge following hospitalization for AMI between 2007 and 2009.8 Thirty-day 
hospital readmission rates have become a quality performance measure for patients 
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hospitalized with AMI,7,29 since the Centers for Medicare & Medicaid Services (CMS) 
began publicly reporting 30-day risk-standardized readmission rates (RSRRs) for heart 
failure (HF), AMI, and pneumonia as performance measures after these measures were 
endorsed by the National Quality Forum.29  
A systematic review31 of patient-level predictors of hospital readmission (ranging 
from 30 days to 1 year post-discharge) after AMI found that all-cause readmission rates 
at 30 days ranged from approximately 11% to 28% across 7 studies that were carried out 
between 1991 and 1999. A recent retrospective cohort study,32 conducted in 3 hospitals in 
Olmsted County, MN, found that 30-day all-cause readmission rates among patients who 
survived their hospitalization for a first AMI were 23% during the period 1987 to 1992, 
22% between 1993 and 1998, 22% between 1999 and 2004, and 19% during the most 
recent 5 year period under study (2005 to 2010); comorbid conditions, longer length of 
the original hospital stay, and complications of angiography and revascularization or 
reperfusion were associated with increased risk of 30-day readmissions after a first AMI.  
Although several studies have reported 30-day readmission rates among patients 
surviving an AMI,31,32 and few have examined potential risk factors for 30-day 
readmissions using multivariable regression analyses, there are very little contemporary 
data that describe long-term trends in all-cause and cause specific 30-day readmission 
rates. Moreover, few studies have examined factors such as patient demographics, 
comorbid conditions, in-hospital development of complications, and treatment practices 
during hospitalization that may be associated with 30-day readmissions among patients 
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surviving an AMI in the US, particularly from a more broad population-based 
perspective.  
In study Aim 2, we used data from the WHAS12–15 to examine contemporary 
trends in all-cause and cause-specific (e.g., AMI, CVD-related (except AMI), non CVD-
related) 30-day readmission rates among residents of central Massachusetts discharged 
from three major medical centers in central MA after an AMI over a decade long period 
(1999-2009). This study also described patient characteristics, treatment practices, and 
prognostic factors associated with an increased risk of all-cause 30-day readmissions in 
patients surviving hospitalization for an AMI.  
 
Aim 3: Long-term all-cause mortality rates among patients after a first AMI 
Although CVD remains a leading cause of death and disability, and a major 
burden on health care systems in the US,1,33 there have been ongoing improvements in 
hospital and long-term survival among patients after AMI during the past several 
decades.11,19 The encouraging declines in long-term mortality among patients hospitalized 
with AMI are attributable to a number of factors including improvements in the primary 
prevention of AMI and more widespread use of coronary reperfusion and 
revascularization procedures and effective cardiac medications.11,19 Despite these 
encouraging trends, approximately 1 in every 7 patients discharged from the hospital 
after an AMI will die during the next year.34  
Several studies have reported improvements in long-term survival after hospital 
discharge for AMI;11,19 however, there are little data describing post-hospital discharge 
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death rates among patients hospitalized with a first AMI, especially from the more 
generalizable perspective of a population-based investigation. It has been estimated that 
approximately 620,000 Americans will develop a first AMI annually.1 Given present 
trends of an increasingly older patient population with a greater prevalence of 
comorbidities,11,19,20 the management of patients hospitalized with a first AMI presents 
significant challenges to health care providers. Inasmuch, the need for contemporary 
monitoring of long-term prognosis of this patient population remains important, and the 
identification of factors associated with an increased risk of dying after hospital discharge 
for an initial AMI.  
There are very little population-based data that have examined contemporary 
trends in long-term survival, and factors associated with long-term mortality, among 
patients discharged from the hospital after a first AMI in the U.S.35 In addition, although 
previous studies have observed that  patients discharged from the hospital after NSTEMI 
have a worse long-term prognosis than those with STEMI,36,37 very little population-
based analysis has been performed to examine the association between STEMI/NSTEMI 
and long-term mortality among patients who survived a first AMI. A Spanish study 
conducted in 6 public hospitals has shown that patients with NSTEMI experienced a 
worse 7-year mortality rate than patients with STEMI.37 A recent Danish nationwide 
population-based study examined 25 year trends in first time hospitalizations for AMI 
and showed that the 1-year overall mortality declined from 42.1% (during 1984–1988 to 
24.2% during 2004–2008; comorbidity burden was a strong predictor of 1-year 
mortality.38 In addition, it remains of importance to examine whether the increased use of 
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effective cardiac medications and intervention approaches during recent years has 
resulted in an improved outlook for hospital survivors of a first AMI. 
In study Aim 3, we examined changing trends in long-term prognosis among 
residents of central Massachusetts discharged from all central MA medical centers after a 
first AMI over an approximate 35-year period (1975-2009). Although limited by the 
nonrandomized nature of this study, we examined the impact of various treatment 
regimens (i.e., effective cardiac medications, and coronary diagnostic and interventional 
procedures) on the 1-year post-discharge mortality patterns observed during the years 
under study. Data from the WHAS were used for this investigation.12–15 
 
1.3 Research Design and Methods  
The aims of this dissertation were to examine trends in the extent of delay in the 
receipt of a primary PCI in patients hospitalized with STEMI, and factors associated with 
failure to receive a primary PCI within the current guideline-recommended time frame; to 
examine trends in 30-day hospital readmission rates from all causes, and specific causes, 
over time and factors associated with readmission among patients hospitalized with AMI; 
to examine trends in long-term prognosis, and hospital treatment practices associated 
with all-cause 1-year mortality post-hospitalization, among patients hospitalized for a 
first AMI. This dissertation will analyze secondary data collected  in the WHAS.12–15  
 
1.3.1 Study Designs, Participating Hospitals, and Patient Populations 
The Worcester Heart Attack Study (WHAS) 
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The WHAS12–15 is one of the largest ongoing population-based investigations of 
CHD in the world. This observational study is examining long-term trends in the 
descriptive epidemiology of AMI in residents of the Worcester, MA, metropolitan area 
(2000 census= 478,000) hospitalized at all 16 greater Worcester medical centers in 
Central Massachusetts. Data have been collected on an approximately biennial basis 
during 1975, 1978, 1981, 1984, 1986, 1988, 1990, 1991, 1993, 1995, 1997, 1999, 2001, 
2003, 2005, 2007, 2009, and recently 2011, which presently includes a total of 18 
cohorts.12–15 In 2000, the median age of residents of the Worcester Standard Metropolitan 
Statistical Area was 37 years, 49% were men, 89% were white, and approximately 25% 
had a bachelor’s degree or higher.15 Due to hospital closures, mergers, or conversion to 
long-term care or rehabilitation facilities, fewer hospitals (n=11) have been providing 
care to greater Worcester residents during more recent study years. The 11 acute care 
general hospitals include 2 in the city of Worcester (UMass Memorial Health Care and 
St. Vincent/Worcester Medical Center), and 9 hospitals in the Worcester metropolitan 
area (Clinton, Harrington Memorial, Health Alliance, Henry Heywood, Hubbard, 
Marlboro, Metrowest, Milford-Regional and Wing). A particular strength of the WHAS 
is the ability to examine contemporary and long-term trends in the clinical epidemiology 
of AMI among residents of the Worcester metropolitan area hospitalized at all greater 
Worcester, MA, medical centers.    
    
Methods for identifying cases of AMI 
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Computerized printouts of primary and secondary discharge diagnoses of AMI 
and related acute and chronic coronary disease rubrics were obtained from all 
participating greater Worcester medical centers for purposes of identifying possible cases 
of AMI occurring during the periods under study. The PI and the project director of the 
WHAS reviewed the appropriate (9th and/or 10th) International Classification of Disease 
(ICD) codes for CHD at participating metropolitan Worcester hospitals. The 9th revision 
ICD codes included codes 410-414 and 786.5 and the corresponding 10th revision codes 
of I20-I25 and R07. The vast majority of validated cases of AMI came from ICD-9 
diagnostic rubric 410 (AMI), followed by a small number of cases from ICD rubric 411 
(other acute and sub-acute forms of CHD). An extremely low yield of cases of definite 
AMI have come from ICD rubrics 412 (old MI), 413 (angina pectoris), 414 (other forms 
of chronic CHD), and 786.5 (chest pain); these latter disease categories primarily 
included patients with chronic manifestations of CHD or nonspecific chest pain. 
 
Diagnostic criteria for validating AMI 
Cases of possible AMI treated at all greater Worcester medical centers were 
validated according to predefined criteria for AMI. This diagnosis was made on the basis 
of the well accepted criteria developed by the World Health Organization which includes 
a supportive clinical history, increases in serum enzyme levels, and serial 
electrocardiographic findings; these criteria have been utilized in a number of clinical and 
epidemiological investigations including the MONICA study.39 These diagnostic criteria 
included:  
  16 
 
 
 a suggestive clinical history (i.e., a typical history of prolonged chest pain 
suggestive of AMI that is not relieved by rest and/or use of nitrates) 
 increases in several serum biomarkers (e.g., creatine kinase (CK), CK-MB, 
and troponin values) 
 serial electrocardiographic findings during hospitalization consistent with the 
presence of AMI 
 
Study inclusion and exclusion criteria 
Patients who satisfied at least 2 of these 3 diagnostic criteria, and were residents 
of the Worcester metropolitan area, were included in this study. Patients who developed 
AMI secondary to an interventional procedure or surgery were excluded from the study 
sample. Additional exclusion criteria were set for each of the 3 aims. 
Aim 1: We restricted our study population to those who were hospitalized with 
STEMI and received a primary PCI during 1999-2009, since our goal was to examine 
contemporary trends in door-to-balloon time and in-hospital delay to a primary PCI based 
on a guideline recommended time interval initiated in 1999.40 
Aim 2: We restricted our study population to those who survived their 
hospitalization for AMI during 1999-2009, since our goal was to examine 30-day 
readmission rates among hospital survivors; 30-day readmission rates, and reasons for 
these hospital readmissions, were also only collected between 1999 and 2009. 
Aim 3: We restricted our study population to those who were hospitalized for a 
first AMI and survived their hospitalization between 1975 and 2009. Patients with an 
  17 
 
 
initial AMI were identified by either mention in the review of the hospital charts that this 
was the patient’s first admission for an AMI or through the review of previous hospital 
records and electrocardiograms that failed to indicate the occurrence of a previous AMI. 
The approaches used to ascertain survival status after hospital discharge included a 
review of records for additional hospitalizations and a statewide and national search of 
death certificates for residents of the Worcester metropolitan area, which resulted in a 
high follow-up rate of greater than 99%. 
 
Data collection  
Trained nurses and physicians abstracted information on patients’ demographic 
characteristics, medical history, clinical data, and treatment practices through the review 
of hospital medical records. These factors included patient's socio-demographic 
characteristics (e.g., age, sex, race, marital status), year of hospitalization, hospital length 
of stay, time of hospital admission (time of day, day of week), history of previously 
diagnosed comorbidities (e.g., hypertension, stroke, diabetes, and heart failure), AMI 
order (initial vs. recurrent), AMI type (STEMI vs. NSTEMI), and the development of 
important in-hospital complications (e.g., atrial fibrillation, cardiogenic shock, heart 
failure, and stroke). Data on several coronary diagnostic and interventional procedures 
[cardiac catheterization, PCI, and coronary artery bypass grafting (CABG)] during 
hospitalization, and medications during hospitalization and at the time of hospital 
discharge, including the prescribing of several effective cardiac medications [angiotensin 
converting inhibitors (ACE-I)/angiotensin receptor blockers (ARBs), anticoagulants, lipid 
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lowering agents, beta blockers, channel blockers, and aspirin], were obtained. Data on 
time interval from hospital emergency department presentation to receiving a primary 
PCI, mode of transportation to the hospital, 1-year post-hospital discharge all-cause death 
rates, and all-cause, and cause-specific, hospitalizations which occurred within 30 days 
after hospital discharge were also collected. 
 
Characteristics of the WHAS Population over Time 
Table 1-1 describes changes in the WHAS population over time (1975-2009). 
There have been relatively significant increases in the age profile of greater Worcester 
residents hospitalized with AMI as well as in the proportion of patients presenting with 
previously diagnosed diabetes, heart failure, hypertension, and stroke. In terms of clinical 
complications, although the proportion of patients developing atrial fibrillation increased, 
the proportions of patients developing heart failure and cardiogenic shock decreased over 
the years under study. The proportion of patients hospitalized with an initial AMI 
remained relatively stable. Despite the presence of an increasingly older patient 
population with a greater prevalence of comorbidities, in-hospital mortality rates declined 
appreciably over time. The hospital length of stay also declined significantly during the 
years under study. 
 
Table 1-1 Characteristics of the Worcester Heart Attack Study Population, 1975-
2009 
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Characteristics 1975-1984 1986-1997 1999-2009 
  (n=3,338) (n=5,998) (n=6,018) 
Age (mean, years) 66.5 68.9 70.3 
Male (%) 62.2 58.3 56.4 
White (%) 97.6 96.4 93.5 
Married (%) 64.0 60.8 53.7 
Q-Wave (%) 61.1 42.5 22.3 
ST-segment myocardial infarction (%) N/A N/A 34.9 
Initial AMI (%) 65.2 65.4 64.4 
In-hospital case-fatality rates  (CFR) 19.0 14.3 10.1 
Medical history (%) 
   
  Heart failure  14.9 17.0 24.4 
  Hypertension 45.7 54.9 72.0 
  Stroke 6.9 9.8 11.8 
  Diabetes 22.4 27.8 33.7 
In-hospital complication (%)  
   
  Atrial fibrillation 15.7 15.6 19.9 
  Cardiogenic shock 7.2 7.1 5.5 
  Stroke N/A 1.3 1.8 
  Heart failure 43.2 38.3 37.8 
Hospital length of stay (mean, days) 15.7 9.5 5.6 
 
  20 
 
 
Human subjects 
The Worcester Heart Attack Study (WHAS) protocol was reviewed and approved 
by the Institutional Review Board at the University of Massachusetts Medical School 
(UMMS). There was no additional data collection for the proposed study. All the 
analyses proposed in this study were conducted using secondary data sets from the 
WHAS. All identifiers were removed from the study data sets by the WHAS data 
coordinating center, so none of the investigators on this study had access to identifiers 
that can link data to subjects. 
 
1.3.2 Measures 
Aim 1: Association between time period of hospitalization and failure to receive a 
primary PCI within 90 minutes after hospital presentation 
Data source: WHAS 1999-2009 
Outcome variable 
The main outcome variable was delay to receipt of a primary PCI, which was 
defined as the time interval from hospital emergency department presentation to receipt 
of a primary PCI. Data abstractors were instructed to use time of first balloon inflation as 
the time of primary PCI. Delay to receipt of a primary PCI was categorized into ≤90 vs. 
>90 minutes, based on clinical guidelines that patients with STEMI receive a primary PCI 
within 90 minutes after emergency department presentation.3 
Key exploratory variable 
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The main exploratory variable was year of hospitalization. For ease of analysis 
and interpretation, we aggregated the 6 individual study years (1999, 2001, 2003, 2005, 
2007, and 2009) into approximate 3 time strata (1999/2001, earliest; 2003/2005, middle; 
and 2007/2009, most recent) for purposes of examining changing trends in our primary 
and secondary study outcomes. 
Covariate Measures 
Candidate variables considered as potential confounders/predictors were chosen 
based on findings from prior studies. These potential confounding variables included 
socio-demographic and clinical characteristics (Table 1-2). 
 
Table 1-2 Covariate measures for Aim 1 
Type Variables 
socio-demographic self-reported age (<55, 55-64, 65-74, and ≥75 years), sex, 
race (white vs. non-white), marital status 
history of previously 
diagnosed comorbidities 
angina, atrial fibrillation, heart failure, hypertension, 
peripheral vascular disease, stroke, diabetes, chronic 
obstructive pulmonary disease, depression, and chronic 
kidney disease, and prior coronary revascularization (PCI or 
CABG surgery) 
AMI order initial or prior 
clinical presentation at 
hospital admission 
heart rate (beats/min), systolic blood pressure (mmHg) 
diastolic blood pressure (mmHg) 
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laboratory findings at 
hospital admission 
glucose (mg/dl), creatinine (mg/dl) 
hospital emergency 
department arrival  
time of day (12 am-5:59 am; 6 am-11:59 am; 12 pm-5:59 pm 
and 6 pm-11:59 pm), day of week (weekday vs. weekend); 
mode of transportation 
 
Aim 2: Association between time period of hospitalization and 30-day all-cause 
hospital readmissions  
Data source: WHAS 1999-2009 
Outcome variable 
The main outcome variable was 30-day all-cause hospital readmissions among 
patients discharged from 3 major greater Worcester medical centers after AMI. We 
analyzed available data from medical record abstractions on all-cause, and cause-specfiic, 
hospitalizations occurring within 30 days after hospital discharge for AMI between 1999 
and 2009.  
Key exploratory variable 
The main exploratory variable was year of hospitalization. For ease of analysis 
and interpretation, we aggregated the 6 individual study years (1999, 2001, 2003, 2005, 
2007, and 2009) into approximate 3 time strata (1999-2001, earliest; 2003-2005, middle; 
and 2007-2009, most recent) for purposes of examining changing trends in our primary 
study outcomes. 
Covariate Measures 
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Candidate variables considered as potential confounders/predictors were chosen 
based on findings from prior studies. These potential confounding variables included 
socio-demographic and clinical determinants (Table 1-3). 
 
Table 1-3 Covariate measures for Aim 2 
Type Variables 
socio-demographic self-reported age (<55, 55-64, 65-74, 75-84, and ≥85 years), 
sex, race (white vs. non-white), marital status 
history of previously 
diagnosed comorbidities 
angina, atrial fibrillation, heart failure, hypertension, 
peripheral vascular disease, stroke, diabetes, chronic 
obstructive pulmonary disease, depression, and chronic 
kidney disease 
hospital length of stay days of hospitalization 
AMI type STEMI, NSTEMI 
AMI order initial or prior 
development of important 
in-hospital complications 
atrial fibrillation, cardiogenic shock, heart failure, stroke 
clinical presentation at 
hospital admission 
heart rate (beats/min), systolic blood pressure (mmHg) 
diastolic blood pressure (mmHg) 
laboratory findings at 
hospital admission 
glucose (mg/dl), creatinine (mg/dl) 
in-hospital management thrombolytic therapy, cardiac catheterization, PCI, and 
coronary artery bypass grafting (CABG) 
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medication at hospital 
discharge 
angiotensin converting inhibitors (ACE-I)/angiotensin 
receptor blockers (ARBs), aspirin, beta blockers, and  lipid 
lowering agents 
 
Aim 3: Association between time period of hospitalization and 1-year post-hospital 
discharge all-cause mortality after a first AMI  
Data source: WHAS 1975-2009 
Outcome variable 
The main outcome variable was 1-year post-hospital discharge all-cause mortality 
among patients hospitalized for a first AMI. Patients with an initial AMI were identified 
by either mention in the review of the hospital charts that this was the patient’s first 
admission for an AMI or through the review of previous hospital records and 
electrocardiograms that failed to indicate the occurrence of a previous AMI. The 
approaches used to ascertain survival status after hospital discharge included a review of 
medical records for additional hospitalizations and a statewide and national search of 
death certificates using the Social Security Death Index Records for residents of the 
Worcester metropolitan area; follow-up was available through the end of 2012. 
Key exploratory variable 
The main exploratory variable was year of hospitalization. For ease of analysis 
and interpretation, we aggregated the 17 individual study years (1975, 1978, 1981, 1984, 
1986, 1988, 1990, 1991, 1993, 1995, 1997, 1999, 2001, 2003, 2005, 2007, and 2009) into 
approximate 3 decade-long time strata (1975-1984, earliest; 1986-1997, middle; and 
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1999-2009, most recent) for purposes of examining changing trends in our primary study 
outcomes. 
Covariate Measures 
Candidate variables considered as potential confounders/predictors were chosen 
based on findings from prior studies. These potential confounding variables included 
socio-demographic and clinical factors (Table 1-4). 
 
Table 1-4 Covariate measures for Aim 3 
Type Variables 
socio-demographic self-reported age (<55, 55-64, 65-74, 75-84, and ≥85 years), 
sex, race (white vs. non-white), marital status 
history of previously 
diagnosed comorbidities 
angina, atrial fibrillation, heart failure, hypertension, 
peripheral vascular disease, stroke, diabetes, chronic 
obstructive pulmonary disease, depression, and chronic 
kidney disease 
hospital length of stay days of hospitalization 
AMI type Q-wave, non-Q-wave; STEMI, NSTEMI 
development of important 
in-hospital complications 
atrial fibrillation, cardiogenic shock, heart failure, stroke 
clinical presentation at 
admission 
heart rate (beats/min), systolic blood pressure (mmHg) 
diastolic blood pressure (mmHg) 
laboratory findings at 
admission 
glucose (mg/dl), creatinine (mg/dl) 
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in-hospital management thrombolytic therapy, cardiac catheterization, PCI, and 
coronary artery bypass grafting (CABG) 
medication at hospital 
discharge 
angiotensin converting inhibitors (ACE-I)/angiotensin 
receptor blockers (ARBs), aspirin, beta blockers, and  lipid 
lowering agents 
 
1.3.3 Statistical Analyses 
Similar analytic approaches were used to address each of the 3 study aims. These 
approaches included descriptive analyses of the study sample characteristics, and simple 
regression analysis followed by multivariable-adjusted regression modeling, which was 
carried out to examine the three aims of this dissertation. Comparisons between various 
patient groups were carried out using the chi-square tests for categorical variables, and 
the ANOVA tests for continuous variables. The Cochran-Armitage tests and linear 
regression models were used to test for linear trends over time among categorical and 
continuous variables, respectively. All analyses were performed using SAS 9.3. 
 
Aim 1: Association between time period of hospitalization and failure to receive a 
primary PCI within 90 minutes after hospital presentation: WHAS 1999-2009 
Poisson regression models with robust error variance41 were used to examine the 
association between the 3 time strata (1999/2001, earliest; 2003/2005, middle; and 
2007/2009, most recent) and failure to receive a primary PCI within 90 minutes (≤90 
vs.>90 minutes) of hospital arrival, and to determine factors associated with this 
outcome.  
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In each analysis, a series of regression models were used to adjust for the 
potentially confounding influence of socio-demographic characteristics, comorbidities, 
and in-hospital factors on the association between time and failure to receive a primary 
PCI within 90 minutes after hospital emergency department arrival for patients 
hospitalized with STEMI. For model building, potential confounders/predictors were 
selected based on a review of the published literature; other analytic approaches including 
forward selection and backward elimination were considered and compared. The 
unadjusted model included only time of hospitalization. Multivariable-adjusted 
regression models further adjusted for factors, such as socio-demographics, medical 
history of various cardiovascular diseases, and comorbidities and in-hospital factors.  
 
Aim 2: Association between time period of hospitalization and 30-day all-cause 
hospital readmissions: WHAS 1999-2009 
Logistic regression analyses42 were used to examine the association between the 3 
time strata (1999/2001, earliest; 2003/2005, middle; and 2007/2009, most recent) and 30-
day all-cause hospital readmissions (yes vs. no), and to determine factors associated with 
30-day all-cause readmission. Similar simple regression analyses followed by 
multivariable regression modeling adjusting for several potentially confounding/predictor 
variables of prognostic importance as described previously in aim 1 were performed. We 
also examined the specific causes of 30-day hospital readmissions by time period of 
hospitalization.  
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Aim 3: Association between time period of hospitalization and 1-year post-hospital 
discharge all-cause mortality: WHAS 1975-2009 
Logistic regression analyses42 were performed to examine the association between 
the 3 time strata (1975-1984, earliest; 1986-1997, middle; and 1999-2009, most recent) 
and 1-year post-hospital discharge all-cause mortality (dead vs. alive) and to determine 
factors associated with these outcomes. Similar simple regression analyses followed by 
multivariable regression modeling adjusting for several potentially confounding variables 
of prognostic importance as described previously in aim 1 were performed.  
 
1.4 Summary  
In summary, AMI remains a significant public health and clinical concern. There 
is a need for contemporary epidemiologic research that examines treatment practices with 
regards to the extent of delay in door-to-balloon time, 30-day hospital readmission rates, 
long-term post-hospital all-cause mortality, and factors associated with these outcomes 
among patients hospitalized for an AMI.  
This study would contribute to the current literature in the management of patients 
hospitalized with AMI for several reasons. First, our investigation provided relatively 
contemporary and long-term trends into the changing magnitude of prognostic factors 
and outcomes and identified at-risk patients for 30-day hospital readmissions, which will 
be valuable to help evaluate current health policy and management guideline and inform 
necessary policy change. Second, our study benefited from the ability to track long-term 
trends in predictors and outcomes among patients hospitalized for an AMI, as these 
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trends remain particularly important to monitor from a community-wide perspective, 
where the characteristics of patients studied have been shown to differ from those 
enrolled in clinical trials where more restrictive inclusion/exclusion criteria may be 
applied and generalizability has been limited.43 Finally, the findings of the proposed 
research provided useful information that can inform the design of novel public health 
interventions and clinical guidelines to improve the short and long-term prognosis of men 
and women hospitalized with AMI.  
Aim 1: our results could be used to identify at-risk patients hospitalized with 
STEMI for failure to receive a primary PCI within the current guideline recommended 
time frame and lead to the design of interventions to improve door-to-balloon time. 
Aim 2: our results highlighted contemporary population-based trends in 30-day 
readmission rates and specific reasons for 30-day readmissions among patients 
discharged with AMI. Our results also helped to identify patient and clinical factors that 
place patients at higher risk for 30-day hospital readmissions, which can be used to 
design patient-centered post-discharge care to prevent subsequent readmissions and 
improve long-term outcomes. 
Aim 3: our results provided insights into the changing characteristics, 
management practices, long-term outcomes, and potential impact of effective cardiac 
treatment approaches during the patient’s index hospitalization in association with 
changes in long-term mortality among patients who survived their hospitalization for a 
first AMI. These results can hopefully lead to the development of innovative, patient-
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centered, intervention strategies which can improve the long-term outcomes among 
patients after a first AMI. 
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CHAPTER 2 : DECADE-LONG TRENDS IN DELAY TO 
THE RECEIPT OF A PRIMARY PERCUTANEOUS 
CORONARY INTERVENTION IN PATIENTS 
HOSPITALIZED WITH ST-SEGMENT ELEVATION 
MYOCARDIAL INFARCTION 
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Abstract 
Background 
There are limited data available describing contemporary trends in door-to-balloon time 
among patients hospitalized with ST-segment elevation myocardial infarction (STEMI) 
who receive a primary percutaneous coronary intervention (PCI) in the broader 
community setting. We examined decade-long trends (1999-2009) in, and factors 
associated with, door-to-balloon time within 90 minutes among patients hospitalized with 
STEMI. 
Methods 
Residents of the Worcester, MA, metropolitan area hospitalized with STEMI and 
receiving a primary PCI at 3 PCI-capable medical centers on a biennial basis (1999-2009) 
comprised the study population (n=548). Multivariable Poisson regression analyses were 
used to examine the factors of failing to receive a primary PCI within 90 minutes after 
emergency department (ED) arrival. 
Results 
The average age of this population was 61.8 years, 31.2% were women, and 92.0% were 
white. During the years under study, 43.2% of patients received a primary PCI within 90 
minutes of ED arrival; this proportion increased dramatically from 1999/2001 (11.6%) to 
2007/2009 (70.5%) in crude as well as multivariable adjusted analyses. Older age, having 
previously diagnosed diabetes and chronic kidney disease, prior CABG surgery, and 
arriving at the ED by car/walked-in and during off-hours were significantly associated 
with a higher risk of failing to receive a primary PCI within 90 minutes. 
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Conclusions 
The likelihood of receiving a timely primary PCI in patients hospitalized with STEMI 
increased dramatically during the years under study. Several high risk groups were 
identified for purposes of heightened surveillance and intervention efforts to reduce the 
likelihood of failing to receive a timely primary. 
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2.1 Introduction 
The prompt administration of coronary reperfusion therapy for patients with an 
evolving acute myocardial infarction (AMI) is crucial in reducing mortality and the risk 
of serious clinical complications in these patients.3 During the past decade, primary 
percutaneous coronary intervention (PCI) has gradually replaced thrombolysis as the 
main revascularization strategy for patients presenting with ST-segment elevation 
myocardial infarction (STEMI), since primary PCI has been found to be superior to 
thrombolytic therapy when performed rapidly by expert teams.2 Because the 
effectiveness of a primary PCI may be limited by delays in its prompt delivery, current 
clinical guidelines have recommend a door-to-balloon time of 90 minutes or less for 
patients hospitalized with STEMI who undergo a  primary PCI.3  
To date, there are little population-based data available describing contemporary 
trends in the magnitude of, and factors associated with, door-to-balloon times in patients 
experiencing an STEMI;5,6,27,28 the limited studies in this area have shown mixed results 
of improvement in door-to-balloon time during varying study years and an inconsistent 
profile of patients who fail to be treated within recommended guidelines.5,6,27,28 
Inasmuch, there is a need to describe relatively contemporary long-term trends in the 
extent of, and potential risk factors associated with, delays in door-to-balloon time among 
patients hospitalized with STEMI, particularly from the more generalizable perspective 
of a population-based investigation.  
The primary objective of our observational study was to describe decade-long 
(1999-2009) trends in the extent of delay from hospital emergency department 
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presentation to initiation of a primary PCI among patients hospitalized with STEMI. Our 
secondary objective was to examine factors associated with the failure to receive a 
primary PCI within 90 minutes among patients hospitalized with STEMI. Data from the 
Worcester Heart Attack Study were used for purposes of this investigation.12–15 
 
2.2 Methods 
  Described elsewhere in detail,12–15 the Worcester Heart Attack Study is an 
ongoing population-based investigation examining long-term trends in the descriptive 
epidemiology of AMI in residents of the Worcester, MA,  metropolitan area (2000 
census= 478,000) hospitalized at all 16 medical centers in Central Massachusetts on an 
approximate biennial basis between 1975 and 2009.12–15 Due to hospital closures, 
mergers, or conversion to long-term care or rehabilitation facilities, fewer hospitals 
(n=11) have been providing care to greater Worcester residents during the most recent 
years under study.       
Computerized printouts of patients discharged from all greater Worcester 
hospitals with possible AMI [International Classification of Disease (ICD) 9 codes: 410-
414, 786.5] were identified. Cases of possible AMI were independently validated using 
predefined criteria for AMI;12–15 these criteria included a suggestive clinical history, 
increases in several serum biomarkers (e.g., creatine kinase (CK), CK-MB, and troponin 
values), and serial electrocardiographic findings during hospitalization consistent with the 
presence of AMI. Patients who satisfied at least 2 of these 3 criteria, and were residents 
of the Worcester metropolitan area since this study is population-based, were included. A 
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diagnosis of STEMI was made when new ST-segment elevation was present at the J point 
in 2 or more contiguous leads.44  
For purposes of the present study, we restricted our sample to adult residents of 
the Worcester metropolitan area who were hospitalized with STEMI and received a 
primary PCI between 1999 and 2009. Patients who received thrombolytic therapy during 
hospitalization were excluded since they did not meet the criteria for receiving a primary 
PCI. Door-to-balloon time was defined as the time interval from the patient’s arrival at 
the hospital emergency department to inflation of the balloon to restore coronary flow. 
Patients who were transferred from another hospital were excluded, since the clinical 
guidelines of door-to-balloon time within 90 minutes were recommended for those who 
were initially seen at a PCI-capable hospital. To increase the likelihood that we were 
assessing patients who received a primary PCI, we excluded patients with delay times 
which exceeded 6 hours.27,45 Patients who did not have door-to-balloon times 
documented were also excluded. This study was approved by the Institutional Review 
Board at the University of Massachusetts Medical School. 
 
Data Collection 
Trained nurses and physicians abstracted information on patients’ demographic 
characteristics, medical history, clinical data, and treatment practices through the review 
of hospital medical records. Information on  patient's socio-demographic characteristics 
(e.g., age, sex, race, marital status), year of hospitalization, history of previously 
diagnosed comorbidities (e.g., stroke, diabetes, heart failure), prior coronary 
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revascularization [PCI or coronary artery bypass graft surgery (CABG)], AMI order 
(initial vs. prior), hospital emergency department arrival day and time, mode of 
transportation (car/walked-in vs. ambulance), and door-to-balloon time were collected.  
 
Data Analysis 
For ease of analysis and interpretation, we aggregated the 6 individual study years 
into 3 two-year strata (1999/2001, earliest; 2003/2005, middle; and 2007/2009, most 
recent) for purposes of examining trends in our principal study outcomes. Door-to-
balloon time was further dichotomized as ≤90 vs. >90 minutes, based on  current clinical 
guidelines recommendations.3 Differences in the distribution of patient demographic and 
clinical characteristics between patients hospitalized during the 3 time periods were 
examined using the ANOVA test for continuous variables and the chi-square test for 
categorical variables. The Cochran-Armitage tests and linear regression models were 
used to test for linear trends over time among categorical and continuous variables, 
respectively.  
Delay to the receipt of a primary PCI was examined by calculating mean and 
median door-to-balloon time, and the frequency of receipt of a primary PCI within 90 
minutes among patients hospitalized with STEMI during the years under study. Due to 
the common nature of the primary outcome (i.e., >10%) and the advantage of providing 
relative risk estimates, multivariable adjusted Poisson regression models with robust error 
variance41 were used to examine the association between the main explanatory variable of 
time period of hospitalization (1999-2001, earliest; 2003-2005, middle; and 2007-2009, 
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most recent) and the outcome of whether or not patients failed to receive a primary PCI 
within 90 minutes after hospital emergency department arrival (i.e., door-to-balloon time: 
>90 vs. ≤90 minutes) while adjusting for several potentially confounding variables of 
prognostic importance; hospital dummy variables were included as fixed effects in our 
regression models. Since a linear relationship between the 3 time periods of 
hospitalization and the outcome of failure to receive a primary PCI within 90 minutes 
was not assumed, we dummy coded this variable with the earliest study years 
(1999/2001) serving as the reference group.   
Several covariates associated with delay to the receipt of a primary PCI in patients 
hospitalized with STEMI in prior studies were examined4–6,46 These factors included age, 
sex, race (white vs. non-white), marital status (married vs. not married), previously 
diagnosed comorbid conditions (angina, atrial fibrillation, heart failure, hypertension, 
peripheral vascular disease, stroke, diabetes, chronic obstructive pulmonary disease, 
depression, and chronic kidney disease), prior coronary revascularization (PCI or CABG 
surgery),  AMI order (initial vs. prior), and hospital emergency department arrival time 
(regular hours: 8 am-6 pm, weekday vs. off-hours: before 8 am or after 6 pm, weekday 
and weekend) and mode of transportation (car/walked-in vs. ambulance). We repeated 
these same analyses restricted to patients hospitalized in 2007/2009 to examine factors 
associated with failure to receive a primary PCI within 90 minutes in the most recent 
study cohorts. 
The results of our Poisson regression models with robust error variance were 
presented as multivariable adjusted risk ratios (RR) and accompanying 95% confidence 
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intervals (CI). All statistical analyses were conducted using SAS version 9.3 (SAS 
Institute, Inc, Cary, North Carolina). 
2.3 Results 
Study population characteristics  
The study population consisted of 548 adult residents of the Worcester 
metropolitan area who were hospitalized with STEMI and received a primary PCI at 3 
PCI-capable hospitals in central Massachusetts between 1999 and 2009. Overall, the 
average age of this population was 61.8 years, 31.2% were women, the majority were 
white (92.0 %), and 62.3% were married. In addition, 76.3% of our study sample was 
hospitalized for an initial AMI, 22.0% arrived at participating hospitals either by 
car/walked-in, and 56.8% arrived at the emergency departments during off-hours. There 
was a significant increase in the proportion of patients who presented at the emergency 
departments during off-hours during the years under study (Table 2-1).  
During the most recent years under study, patients who were hospitalized with 
STEMI and received a primary PCI were more likely to have a history of peripheral 
vascular disease, or depression, compared to those hospitalized with STEMI during 
earlier study periods (Table 2-1).  
 
Trends in door-to-balloon time  
The average delay time from the patient’s arrival at the hospital emergency 
department to inflation of the balloon to restore coronary flow during the years under 
study was 110 minutes. There was a marked decrease in this mean delay time from 
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1999/2001 (146 minutes) to 2007/2009 (82 minutes) (Figure 2-1). The median delay time 
from the patient’s arrival at the hospital emergency department to balloon inflation during 
the years under study was 91 minutes. There was also a significant decrease in the 
median duration of delay from 1999/2001 (143 minutes) to 2007/2009 (71 minutes) 
(Figure 2-1). 
Among all study patients who underwent a primary PCI, 43.2% of these patients 
received the intervention within 90 minutes after their emergency department arrival. 
There was a dramatic increase in the proportion of STEMI patients who received a 
primary PCI within guideline-recommended 90 minutes between 1999/2001 (11.6%) and 
2007/2009 (70.5%) (p for trend <0.001) (Figure 2-1). Among all study patients who 
received a primary PCI within 90 minutes, 46.0% were treated during the first hour after 
hospital emergency department arrival; this proportion significantly increased from 
18.2% in 1999/2001 to 53.7% in 2007/2009. 
In examining changing trends in the failure to receive a primary PCI within 90 
minutes, after adjusting for several demographic characteristics and clinical factors, there 
was a significant reduction in the risk of failing to receive a primary PCI within 90 
minutes among patients hospitalized in 2003/2005 (RR=0.82, 95% CI=0.71-0.96) and in 
2007/2009 (RR=0.33, 95% CI=0.26-0.41), compared with those hospitalized in 
1999/2001 (Table 2-2).  
 
Factors associated with failure to receive a primary PCI within 90 minutes 
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Using multivariable adjusted regression analyses, we examined the role of various 
prognostic factors associated with failure to receive a primary PCI within 90 minutes in 
all study patients (Table 2-2). Older age (>75 years), having previously diagnosed 
diabetes and chronic kidney disease, having previously undergone CABG surgery, and 
arriving at the emergency department by car/walked-in and during off-hours were 
significantly associated with a higher risk of failing to receive a primary PCI within 90 
minutes (Table 2-3). When we examined factors associated with failure to receive a 
primary PCI within 90 minutes in the most recent patient populations (2007/2009), 
having previously diagnosed diabetes, and arriving at the emergency department by 
car/walked-in and during off-hours were significantly associated with a higher risk of 
failing to receive a timely primary PCI. 
 
2.4 Discussion 
The results of this observational study suggest that, among greater Worcester 
residents who were hospitalized for an STEMI and received a primary PCI at 3 PCI-
capable hospitals in central MA between 1999 and 2009, there was a 6 fold increase in 
the proportion of patients who received a primary PCI within guideline-recommended 90 
minutes during the years under study. Older age, having previously diagnosed diabetes 
and chronic kidney disease, having previously undergone  CABG surgery, and arriving at 
the emergency department by car/walked-in and during off-hours were significantly 
associated with a higher likelihood of failing to receive a primary PCI within 90 minutes 
at participating study hospitals. 
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Trends in, and magnitude of, door-to-balloon time 
Timely medical care is crucial to reducing mortality and the risk of serious 
clinical complications in patients with AMI. This is because it can maximize the benefits 
of evidence-based treatments and possibly reduce the likelihood of sudden cardiac deaths 
and the eventual size of the infarct. Although primary PCI has been shown to improve 
outcomes in patients with STEMI, its effectiveness may be limited by delays in its more 
timely delivery.3 
Since 1999, clinical practice guidelines for the management of patients with 
STEMI have recommended door-to-balloon times of 90 minutes or less.3,40,47 However, 
earlier data from the National Registry of Myocardial Infarction (NRMI), which 
examined 33,647 patients hospitalized with STEMI who received a primary PCI between 
1999 and 2002 at 421 U.S. hospitals, reported that only 35% of patients were treated 
within the recommended 90 minutes after arrival at the hospital; meaningful 
improvements in door-to-balloon times over the study period were not observed.5  
These discouraging findings have led to several national efforts dedicated to 
reducing door-to-balloon time in patients hospitalized with STEMI. The Centers for 
Medicare and Medicaid Services (CMS) and the Joint Commission began using door-to-
balloon time as a performance measure in 2002.48 In 2006, the CMS began publicly 
reporting hospital achievement of door-to-balloon times of 90 minutes or less. In 
November 2006, the American College of Cardiology (ACC), the American Heart 
Association (AHA), and several other organizations launched the "Door to Balloon 
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(D2B): An Alliance for Quality" campaign, with the goal of increasing the percentage of 
STEMI patients who would receive a primary PCI within 90 minutes of presentation at a 
PCI-capable hospital to 75%.49 In May 2007, the AHA launched Mission: Lifeline, 
another national initiative designed to educate patients and providers about the 
importance of rapid response to STEMI and to help hospitals create coordinated STEMI 
diagnostic and  treatment systems.50 
Several studies in the U.S. have shown reductions in door-to-balloon times since 
these national efforts have been employed.6,27,28 Findings from the Blue Cross Blue 
Shield of Michigan Cardiovascular Consortium of 8,771 patients with STEMI who 
underwent a primary PCI between 2003 and  2008 showed that the median door-to-
balloon time had decreased from 113 minutes in 2003 to 76 minutes in 2008 (p<.001). In 
addition, the percentage of patients who were revascularized with a door-to-balloon time 
of less than 90 minutes significantly increased from 29% in 2003 to 67% in 2008 
(p<.001).6 A prior study which examined data from more than 300,000 Medicare patients 
at 900 U.S. hospitals found that door-to-balloon times declined from a median of 96 
minutes in 2005 to 64 minutes in 2010. There were corresponding increases in the 
percentage of patients who had door-to-balloon times <90 minutes (44.2% to 91.4%).27 A 
recent study analyzed data from 96,738 admissions for patients with STEMI who 
underwent a primary PCI from July, 2005 through June, 2009 at 515 U.S. hospitals 
participating in the CathPCI Registry. Median door-to-balloon times declined 
significantly from 83 minutes in the first year to 67 minutes in the most recent study year, 
and the percentage of patients for whom the door-to-balloon time was 90 minutes or less 
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increased from 59.7% to 83.1% during the years under study (p<.001).28 Consistent with 
the timeline of national efforts in reducing door-to-balloon time and prior research 
results, our current study observed, particularly in 2007/2009, a substantial decrease in 
the median door-to-balloon time and a dramatic increase in the proportion of patients 
who received a primary PCI within the guideline-recommended 90 minutes.  
While reducing door-to-balloon times has shown considerable improvements in 
U.S. hospitals over time, some unintended consequences of these efforts merit attention. 
Corresponding to the national effort initiated by the ACC in 2006 to reduce door-to-
balloon times, several strategies and organizational factors associated with shorter door-
to-balloon time have been identified and promoted.51–53 These efforts  including 
encouraging emergency medical service providers and emergency department physicians 
to activate the cardiac catheterization laboratory prior to consultation with a staff 
cardiologist, which may have achieved a significant reduction in door-to-balloon time, 
while increasing the rate of  “false activations” (defined as emergent cardiac 
catheterization laboratory activation when the patient was determined to not require 
emergent transfer from the emergency department to the cardiac catheterization 
laboratory for a primary PCI). Indeed, a prior study of all adult patients with a suspected 
STEMI between 2007 and 2011 at the University of Michigan Hospital noted that the 
median door-to-balloon time decreased from 67 minutes in 2007 to 55 minutes in 2011, 
but the false activation rates increased from 15% to 40% of all cases.54 When the cardiac 
catheterization laboratory is activated emergently, resources must be collected to prepare 
for a potential patient. During off-hours, this often requires bringing in a full team to 
  45 
 
 
begin preparing the cardiac catheterization laboratory. These false cardiac catheterization 
laboratory activations can be a drain on staff and a poor use of resources. Therefore, 
future studies of healthcare system interventions to decrease the rates of false cardiac 
catheterization laboratory activations while maintaining short door-to-balloon times 
remain warranted.  
 
Factors associated with failure to receive a primary PCI within 90 minutes after 
emergency department arrival 
A recent systematic review and meta-analysis examining the association between 
off-hour presentation and outcomes in patients with AMI has suggested that patients with 
STEMI presenting during off-hours have longer door to balloon times.55 A prior study 
examined data from the Get With the Guidelines–Coronary Artery Disease databases 
between 2000 and 2005 found that among the 5,454 patients with STEMI who received a 
primary PCI, those arriving during off-hours were less likely to achieve door-to-balloon 
times ≤90 minutes compared with those arriving during regular-hours.56 In the NRMI 
study of 33,647 patients with STEMI treated with a primary PCI from 1999 to 2002,46 
54% of patients were treated during off-hours; door-to-balloon times were substantially 
longer during off-hours (116 minutes) than regular hours (95 minutes). Longer door-to-
balloon times during off-hours were primarily due to a longer interval between obtaining 
the electrocardiogram and patient arrival at the cardiac catheterization laboratory. 
Similarly, our study observed that patients with STEMI admitted to the emergency 
department during off-hours were more likely to fail to receive a timely primary PCI, 
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compared with those admitted during regular hours. Approaches to provide onsite 
staffing of the cardiac catheterization laboratory and rapid access to interventional 
cardiologists during off-hours, including consideration of the costs of providing such 
coverage, would be beneficial.  
In the current investigation, we found that patients with STEMI who arrived at the 
emergency department by car/walked-in were more likely to fail to receive a primary PCI 
within 90 minutes, compared with those who arrived at the emergency department by 
ambulance. Pre-hospital electrocardiograms (ECGs) have been recommended and are 
increasingly used in the management of patients with chest pain transported by 
emergency medical services (EMS),3 such that paramedics can rapidly diagnose and 
triage patients with a suspected STEMI before hospital arrival. Since hospitals can use 
the pre-hospital ECG results to activate the cardiac catheterization lab while the patient is 
en route to the hospital, door-to-balloon times are shorter than when activation is initiated 
after the patient’s arrival to the emergency department. Several studies have shown that 
the use of pre-hospital ECGs is associated with shorter door-to-balloon times.57,58 A prior 
study analyzed data from the NCDR (National Cardiovascular Data Registry) ACTION 
(Acute Coronary Treatment and Intervention Outcomes Network) registry of 12,097 
patients hospitalized with STEMI in 2007 reported that median door-to-balloon times for 
patients undergoing a primary PCI were significantly shorter for patients with a pre-
hospital ECG .58  
Although our study identified several patient related factors, such as older age, 
history of previously diagnosed diabetes and chronic kidney disease, and having 
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previously undergone CABG surgery, to be significantly associated with failing to 
receive a primary PCI within the guideline-recommended time frame, a prior systematic 
review of various factors associated with door to balloon time in patients with STEMI 
treated with PCI has found mixed findings with regards to the strength of association of 
these factors between studies.59 While these differences in study results may be due to 
differences in study design, definitions of key covariates, patient populations under study, 
and sample size considerations, our study identified several patient groups at high risk for 
failing to be treated in a timely manner in whom further surveillance and/or 
hospital/provider educational efforts might be directed. 
Although several studies, including ours, have suggested encouraging reductions 
in door-to-balloon times over the years, healthcare providers should continue their efforts 
to educate patients about the symptoms of AMI and importance of calling 911 to 
facilitate EMS triage, treatment, and transport to reduce not only in-hospital but also 
prehospital treatment delays. Indeed, delays in patient’s medical care seeking behavior 
following the development of acute coronary symptoms continue to remain unduly long 
and have improved little over time.60,61  
 
Study strengths and imitations 
The strengths of the present community-based study include the examination of 
relatively contemporary decade-long trends in, and factors associated with, door-to-
balloon time among patients hospitalized with STEMI. Several limitations need to be 
acknowledged, however, in the interpretation of the present findings. Since our study 
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population included only patients who had been hospitalized at 3 PCI-capable hospitals in 
central MA, one needs to be careful in extrapolating our findings to those who reside in 
other geographic areas. Because study patients were predominantly white, the 
generalizability of our findings to other race/ethnic groups may be limited. In addition 
there is the potential for unmeasured confounding in any of our observed associations 
since we did not have information available on several patient-associated characteristics, 
such as education, psychosocial factors, and treatment preference, as well as healthcare 
system level factors, which may have affected door-to-balloon times.  
 
Conclusions 
The results of the present investigation provide insights into contemporary trends 
in door-to-balloon time, and potential factors associated with an increased risk of failing 
to receive a primary PCI within guideline-recommended 90 minutes, among patients who 
were hospitalized with STEMI on an alternating yearly basis between 1999 and 2009. 
The likelihood of receiving a primary PCI within guideline-recommended 90 minutes in 
these patients has increased remarkably during the years under study. Although most of 
the identified risk factors for the less than optimal timely receipt of a primary PCI were 
not modifiable, our findings can hopefully lead to better development of innovative, 
patient-centered, intervention strategies which can further reduce the door-to-balloon 
times of patients hospitalized with STEMI. 
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Table 2-1 Characteristics of patients who were hospitalized with an ST-segment elevation myocardial infarction 
(STEMI) and received a primary percutaneous coronary intervention (PCI): Worcester Heart Attack Study, 1999-2009  
 
  
1999-2001 
(N=95) 
2003-2005 
(N=202) 
2007-2009 
(N=215) 
 P Value* P for trend† 
Age, mean, years 61.2 62.3 61.6 0.75 0.77 
Age, %, years 
   
0.24 
 
<55 30.5 33.7 31.8 
  
55-64 28.4 23.8 32.2 
  
65-74 24.2 19.3 14.7 
  
75+ 16.8 23.3 21.2 
  
Female, % 33.7 30.7 30.7 0.84 0.65 
White, % 91.9 92.9 91.5 0.86 0.78 
Married, % 72.5 56.9 63.0 0.04 0.35 
Initial AMI, % 73.7 77.7 76.1 0.74 0.79 
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Emergency department off-hours arrival, % 43.2 57.9 61.0 0.011 0.006 
Transport to hospital by car/walked-in, % 13.6 25.5 21.9 0.09 0.34 
Medical history 
     
Angina, % 18.9 11.4 3.6 <.0001 <.0001 
Atrial fibrillation, % 5.3 4.0 3.2 0.66 0.37 
Heart failure, % 5.3 7.9 5.2 0.44 0.69 
Hypertension, % 60.0 60.4 60.6 0.99 0.93 
Peripheral vascular disease, % 4.2 8.9 14.3 0.015 0.004 
Stroke, % 6.3 6.4 2.0 0.043 0.028 
Diabetes, % 32.6 21.3 24.7 0.11 0.30 
Chronic obstructive pulmonary disease, % 8.4 11.9 9.6 0.59 0.99 
Depression, % 5.3 13.9 17.9 0.011 0.003 
Chronic kidney disease, % 5.3 8.9 10.4 0.33 0.15 
Prior percutaneous coronary intervention, % 14.7 18.8 21.9 0.30 0.13 
Prior coronary artery bypass graft surgery, % 5.3 4.0 4.4 0.88 0.81 
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Physiological parameters on admission 
     
Initial heart rate, mean, beats/min 78.8 78.6 79.2 0.95 0.86 
Systolic blood pressure, mean, mmHg 133.5 135.5 138.4 0.35 0.19 
Diastolic blood pressure, mean, mmHg 81.0 78.4 81.7 0.21 0.79 
Serum glucose, mean, mg/dL 175.9 166.2 162.8 0.31 0.13 
Estimated glomerular filtration rate, mean,  mL/min per 
1.73 m2 
72.1 68.4 62.1 <.0001 <.0001 
* P-values derived from ANOVA tests for continuous variables and chi-square tests for categorical variables.  
† P-values derived from Cochran-Armitage tests for categorical variables and linear regression models for continuous 
variables.  
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Table 2-2 Association between time period of hospitalization and failure to receive a primary percutaneous coronary 
intervention (PCI) within 90 minutes among patients who were hospitalized with an ST-segment elevation myocardial 
infarction (STEMI): Worcester Heart Attack Study, 1999-2009 
 
 
Failure to receive a 
primary PCI within 90 
minutes 
Adjusted for 
sociodemographics, 
comorbidities, prior 
revascularization * 
Further adjusted for 
in-hospital factors† 
Study Period % Adjusted RR (95% CI) 
1999/2001 88.4 1.00 1.00 
2003/2005 75.7 0.90 (0.79-1.01) 0.82 (0.71-0.96) 
2007/2009 29.5 0.35 (0.28-0.44) 0.33 (0.26-0.41) 
RR: risk ratios; CI: confidence intervals  
* Adjusted for sociodemographics, previously diagnosed comorbid conditions, prior coronary revascularization (PCI or CABG 
surgery), and participating hospitals.  
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† Adjusted for sociodemographics, previously diagnosed comorbid conditions, prior coronary revascularization (PCI or CABG 
surgery), AMI order, emergency department arrival time and mode of transportation, and participating hospitals. 
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Table 2-3 Association between various prognostic factors and failure to receive a primary percutaneous coronary 
intervention (PCI) within 90 minutes among patients who were hospitalized with an ST-segment elevation myocardial 
infarction (STEMI): Worcester Heart Attack Study, 1999-2009 
 
 
Adjusted for 
sociodemographics, 
comorbidities, prior 
revascularization* 
Further adjusted for 
in-hospital factors† 
Factors Adjusted RR (95% CI) 
Age <55 1.00 1.00 
Age 55-64 0.96 (0.78-1.17) 0.93 (0.75-1.14) 
Age 65-74 1.07 (0.86-1.32) 1.04 (0.83-1.30) 
Age 75 1.29 (1.05-1.58) 1.34 (1.09-1.65) 
Female (vs. Male) 1.05 (0.90-1.22) 1.08 (0.92-1.26) 
White (vs. non-White) 0.87 (0.66-1.15) 0.84 (0.62-1.14) 
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Married (vs. not Married) 1.01 (0.88-1.18) 1.02 (0.88-1.19) 
Comorbid condition   
Angina 1.10 (0.91-1.31) 1.19 (0.97-1.45) 
Atrial fibrillation 1.12 (0.84-1.49) 1.20 (0.93-1.56) 
Heart failure 0.97 (0.75-1.26) 0.98 (0.75-1.28) 
Hypertension 0.85 (0.73-0.98) 0.85 (0.74-0.99) 
Peripheral vascular disease 0.85 (0.65-1.10) 0.83 (0.64-1.07) 
Stroke 0.84 (0.60-1.17) 0.82 (0.60-1.13) 
Diabetes 1.23 (1.05-1.44) 1.27 (1.07-1.50) 
Chronic obstructive pulmonary disease 1.10 (0.89-1.35) 1.06 (0.86-1.30) 
Depression 0.86 (0.67-1.10) 0.84 (0.65-1.08) 
Chronic kidney disease 1.16 (0.96-1.40) 1.25 (1.02-1.54) 
Prior PCI 0.98 (0.81-1.19) 0.87 (0.70-1.07) 
Prior CABG surgery 1.53 (1.18-1.99) 1.62 (1.20-2.19) 
Initial AMI (vs. Prior AMI)  0.86 (0.72-1.04) 
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Arrival at emergency department during 
off-hours (vs. regular hours) 
 1.49 (1.28-1.73) 
Arrival at emergency department by 
car/walked-in (vs. ambulance) 
 1.52 (1.29-1.80) 
RR: risk ratios; CI: confidence intervals  
* Adjusted for study period, sociodemographics, previously diagnosed comorbid conditions, prior coronary revascularization 
(PCI or CABG surgery), and participating hospitals. 
† Adjusted for study period, sociodemographics, previously diagnosed comorbid conditions, prior coronary revascularization 
(PCI or CABG surgery), AMI order, emergency department arrival time and mode of transportation, and participating 
hospitals. 
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Figure 2-1 Trends in door-to-balloon time among patients hospitalized with ST-
segment elevation myocardial infarction (STEMI): Worcester Heart Attack Study, 
1999-2009 
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CHAPTER 3 : DECADE-LONG TRENDS IN 30-DAY 
REHOSPITALIZATION RATES AFTER ACUTE 
MYOCARDIAL INFARCTION 
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Abstract 
Background 
There are limited data available describing relatively contemporary trends in 30-day 
rehospitalizations among patients who survive hospitalization after an acute myocardial 
infarction (AMI) in the community setting. We examined decade-long (1999-2009) 
trends in, and factors associated with, 30-day rehospitalizations in patients discharged 
from two central Massachusetts (MA) hospitals after AMI. 
Methods 
Residents of the Worcester, MA, metropolitan area discharged after AMI from two 
central MA hospitals on a biennial basis between 1999 and 2009 comprised the study 
population (n=4,911). Logistic regression analyses were used to examine the association 
between selected factors and 30-day rehospitalizations. 
Results 
The average age of this population was 69 years, 42% were women, and 93% were white. 
During the years under study, 19.1% of patients were rehospitalized within 30 days after 
hospital discharge. Crude 30-day rehospitalization rates decreased from 20.1% in 
1999/2001 to 16.7% in 2007/2009. After adjusting for several patient characteristics, 
there was a trend toward a reduced odds of being rehospitalized in 2007/2009 (OR=0.79, 
95% CI=0.62-1.00) compared with 1999/2001; this trend was slightly attenuated after 
further adjustment for hospital treatment practices. Female sex, having previously 
diagnosed diabetes and chronic kidney disease, in-hospital heart failure, and having a ST-
segment elevation MI were associated with an increased odds of being rehospitalized. 
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Conclusions 
The likelihood of being rehospitalized during the first month after hospital discharge for 
AMI remained relatively high during the years under study. Several high risk groups 
were identified for purposes of heightened surveillance and/or intervention efforts to 
reduce the likelihood of being readmitted. 
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3.1 Introduction 
Cardiovascular disease remains the leading cause of morbidity and mortality in 
the United States.1 Acute myocardial infarction (AMI) is a common manifestation of 
underlying coronary heart disease which affected more than 800,000 adults in the U.S. in 
2010.1 Concomitant with advances in pre-hospital and hospital treatment, in-hospital 
survival after AMI has dramatically improved.20 Inasmuch, many patients are being 
discharged from the hospital into the community who are at risk for being readmitted to 
the hospital due to a variety of contributory factors and reasons.31,32 Although not all 
hospital readmissions can be prevented, excess readmissions within a short time frame 
can be a marker of poor quality of care and efficiency. Since the Centers for Medicare 
and Medicaid Services (CMS) began publicly reporting 30-day risk-standardized 
readmission rates for heart failure, AMI, and pneumonia as performance measures,29 30-
day hospital readmission rates have become a quality performance measure for patients 
hospitalized with AMI7,29 
There has been considerable interest from hospitals and clinicians to better 
understand and improve modifiable factors associated with 30-day hospital readmissions, 
which are increasingly being linked to hospital reimbursement.9 Although several studies 
have reported 30-day rehospitalization rates among patients surviving hospitalization for 
AMI,8,32,62 few have examined risk factors for being readmitted to the hospital during the 
following month using multivariable regression analyses. Moreover, there are little 
contemporary data that describe long-term trends in 30-day rehospitalization rates, the 
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reasons for rehospitalization, as well as sociodemographic, clinical, and treatment related 
factors that may affect 30-day rehospitalization rates among patients surviving an AMI.  
Our primary study objective was to describe relatively contemporary decade long 
(1999-2009) trends in the frequency of 30-day rehospitalizations among patients 
surviving hospitalization for an AMI. Our secondary study objective was to describe 
patient characteristics, treatment practices, and clinical factors associated with an 
increased risk of 30-day rehospitalizations among residents of central Massachusetts 
(MA) discharged from the three principal medical centers in central MA after an AMI. 
Data from the Worcester Heart Attack Study were used in this study.12–15  
 
3.2 Methods 
Described elsewhere in detail,12–15 the Worcester Heart Attack Study is an 
ongoing population-based investigation examining long-term trends in the descriptive 
epidemiology of AMI in residents of the Worcester, MA,  metropolitan area (2010 
census=518,000) hospitalized at all 16 medical centers in Central MA on an approximate 
biennial basis between 1975 and 2009. 12–15 Due to hospital closures, mergers, or 
conversion to long-term care or rehabilitation facilities, fewer hospitals (n=11) have been 
providing care to greater Worcester residents during more recent years.    
Computerized printouts of patients discharged from all greater Worcester 
hospitals with possible AMI [International Classification of Disease (ICD) 9 codes: 410-
414, 786.5] were identified and  cases of possible AMI were independently validated 
using predefined criteria for AMI.12–15 These criteria included a suggestive clinical 
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history, increases in several serum biomarkers (e.g., creatine kinase (CK), CK-MB, and 
troponin values), and serial electrocardiographic findings during hospitalization 
consistent with the presence of AMI. Patients who satisfied at least 2 of these 3 criteria, 
and were residents of the Worcester metropolitan area since this study is population-
based, were included. 
Because the focus of the current study was rehospitalization after hospital 
discharge for AMI, we included adult residents of the Worcester metropolitan area who 
survived their index hospitalization for AMI on a biennial basis between 1999 and 2009. 
This time period was selected due to its contemporary nature and data availability. We 
further restricted our study population to patients hospitalized at the three largest tertiary 
care and community medical centers in central MA. This was done since the majority 
(approximately 90%) of patients hospitalized for AMI in central MA was discharged 
from these facilities, which also have excellent electronic medical records. The patient’ 
index hospitalization occurred in either of the three participating hospitals as did any 
subsequent rehospitalization. Patients who had their index hospitalization or the 
rehospitalization outside of these three major medical centers were not included in this 
study. This study was approved by the Institutional Review Board at the University of 
Massachusetts Medical School. 
 
Data Collection 
Trained nurses and physicians abstracted information on patient’s demographic 
characteristics, medical history, clinical data, and treatment practices through the review 
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of hospital medical records. These factors included patient's socio-demographic 
characteristics (e.g., age, sex, race, marital status), year of hospitalization, hospital length 
of stay, history of previously diagnosed comorbidities (e.g., stroke, diabetes, heart 
failure), AMI order (initial vs. prior) and AMI type [ST-segment elevation myocardial 
infarction (STEMI) vs. non-ST-segment elevation myocardial infarction (NSTEMI)].3,24  
Information on the development of important in-hospital complications including atrial 
fibrillation,63 cardiogenic shock,64 heart failure,65 and stroke66 was also collected. 
Data on the receipt of thrombolytic therapy and 3 coronary diagnostic and 
interventional procedures [cardiac catheterization, percutaneous coronary intervention 
(PCI), and coronary artery bypass grafting (CABG)] during hospitalization, and 
pharmacotherapies at the time of hospital discharge, including the prescribing of 4 
effective cardiac medications [angiotensin converting inhibitors (ACE-I)/angiotensin 
receptor blockers (ARBs), aspirin, beta blockers, and  lipid lowering agents], were 
obtained.  
A rehospitalization was defined as the patient’s first admission to a study hospital 
within 30 days of discharge after their index hospitalization for AMI during the years 
under study. The principal reason for being rehospitalized was further categorized into 
either AMI, cardiovascular disease (CVD) (excluding AMI) related, or non-CVD related. 
Indications for CVD related hospitalizations included unstable angina, heart failure, type 
II diabetes mellitus, and chronic ischemic heart disease. Examples of non-CVD related 
hospitalizations included urinary tract infections, hemorrhage, osteoarthritis, and bone 
fractures. 
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Data Analysis 
For ease of analysis and interpretation, we aggregated the 6 individual study years 
into 3 two-year strata (1999/2001, earliest; 2003/2005, middle; and 2007/2009, most 
recent) for purposes of examining trends in our principal study outcomes. Differences in 
the distribution of various patient demographic and clinical characteristics between 
patients hospitalized during the 3 aggregated time periods were examined using the 
ANOVA test for continuous variables and the chi-square test for categorical variables. 
The Cochran-Armitage tests and linear regression models were used to assess for linear 
trends over time among categorical variables and continuous variables, respectively. 
Thirty-day rehospitalization rates were examined by calculating the frequency of 
having a first rehospitalization within 30 days among patients discharged from the 
hospital after their index AMI during the years under study. We examined the reasons for 
being rehospitalized during this period and calculated the cause-specific 30-day 
rehospitalization rates. Multivariable adjusted logistic regression analyses were 
performed to examine the association between the main explanatory variable of time 
period of hospitalization (1999-2001, earliest; 2003-2005, middle; and 2007-2009, most 
recent) and the outcome of whether or not the patient was rehospitalized during the 
following 30 days while adjusting for several potentially confounding variables of 
prognostic importance. Since a linear relationship between the 3 time periods and the 
outcome of 30-day rehospitalizations was not assumed, we dummy coded this variable 
with the earliest period (1999/2001) serving as the reference group.   
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Several covariates associated with rehospitalization after AMI in prior studies31,32 
were examined including age, sex, race (white vs. non-white), marital status (married vs. 
not-married), AMI order (initial vs. prior), AMI type (STEMI vs. NSTEMI), previously 
diagnosed comorbid conditions (angina, atrial fibrillation, heart failure, hypertension, 
peripheral vascular disease, stroke, diabetes, chronic obstructive pulmonary disease, 
depression, and chronic kidney disease), hospital clinical complications (atrial 
fibrillation, heart failure, cardiogenic shock, and stroke), and hospital length of stay. We 
further adjusted for hospital treatment practices, including the  receipt of thrombolytic 
therapy and 3 coronary diagnostic and interventional procedures (cardiac catheterization, 
PCI, and CABG), and the prescribing of 4 guideline recommended cardiac medications 
(ACE-I/ARBs, aspirin, beta blockers, and lipid lowering agents) at the time of hospital 
discharge during the patient’s index hospitalization in our regression analyses to examine 
the potential effects of hospital treatment practices on 30-day rehospitalization trends. We 
repeated the same analyses after excluding patients (n=157) who were not rehospitalized 
but died within the 30-day post-discharge period. To examine factors associated with 30-
day rehospitalization in the most recent study cohorts, we carried out these regression 
analyses restricted to patients hospitalized in 2007/2009. 
The results of our logistic regression analyses were presented as multivariable 
adjusted odds ratios (OR) and accompanying 95% confidence intervals (CI), which were 
calculated based on standard errors clustered at the hospital level to account for potential 
within-hospital correlation with variance adjustment through the use of Morel’s small 
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sample bias correction.67 All statistical analyses were conducted using SAS version 9.3 
(SAS Institute, Inc, Cary, North Carolina). 
 
3.3 Results 
Study population characteristics  
The study population consisted of 4,911 adult residents of the Worcester 
metropolitan area who survived their hospitalization for AMI at the three major central 
MA medical centers between 1999 and 2009 (Table 3-1). Overall, the average age of this 
population was 69.3 years, 42.0% were women, the majority were white (93.2 %), and 
55.1% were married.  
During the most recent years under study, patients who survived an AMI were 
more likely to be younger and have a history of hypertension, peripheral vascular disease, 
depression or chronic kidney disease than patients hospitalized during earlier study 
periods (Table 3-1). Between 1999 and 2009, 35.3% of our study sample was diagnosed 
with a STEMI, which declined from 41.7% in 1999/2001 to 30.7% in 2007/2009. The 
average hospital length of stay in this study population was 5.8 days, which declined over 
time from 6.7 days in 1999/2001 to 4.9 days in 2007/2009 (Table 3-1). In addition, the 
likelihood of developing cardiogenic shock and stroke during hospitalization remained 
relatively low (3.4% and 1.3% overall, respectively) whereas the incidence rates of in-
hospital heart failure and atrial fibrillation were considerably higher (35.3% and 18.7% , 
respectively) over the years under study (Table 3-1).  
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Thirty-day rehospitalization rates  
The overall 30-day rehospitalization rate for patients who survived their index 
AMI during the years under study was 19.1%. The average post-discharge 30-day 
rehospitalization rates decreased from 1999/2001 (20.3%) to 2003/2005 (19.9%) and 
2007/2009 (16.7%) (p for trend=0.013) (Table 3-2). The proportion of patients who were 
rehospitalized was the highest (7.2%) during the first week (0-7 days) after hospital 
discharge, and continued to decrease as the length of post-discharge time increased 
(Figure 3-1). Rehospitalizations which occurred during the first week after hospital 
discharge accounted for 37.7% of all 30-day rehospitalizations; this proportion decreased 
from 39.6% in 1999/2001 to 31.0% in 2007/2009.  
In examining the specific causes of 30-day rehospitalizations, 53.2% of the 
identified rehospitalizations were CVD related (excluding AMI), 37.4% were non-CVD 
related, and 9.4% were due to a recurrent AMI during the years under study. The overall 
cause-specific 30-day rehospitalization rates due to CVD, non-CVD, and AMI were 
10.1%, 7.1%, and 1.8%, respectively, during the years under study (Figure 3-2). The 
average post-discharge 30-day rehospitalization rates due to CVD (excluding AMI) (p for 
trend=0.03) or non-CVD (p for trend=0.03) related reasons decreased during the most 
recent years under study, while no significant differences in 30-day rehospitalization rates 
due to AMI were observed (Figure 3-2).  
In examining changing trends in 30-day rehospitalizations, after  adjusting for 
several demographic characteristics, comorbidities and in-hospital clinical factors,  there 
was no significant difference in the odds of having a 30-day rehospitalization in 
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2003/2005 (OR=0.93, 95% CI=0.69-1.24), but a borderline significant trend toward a 
reduced odds of being rehospitalized during the subsequent 30 days  (OR=0.79, 95% 
CI=0.62-1.00) among patients who survived an AMI in 2007/2009, in comparison with 
those discharged in 1999/2001 (Table 3-2). However, after further adjustment for medical 
procedures and treatments received during hospitalization, there were no significant 
differences in the odds of having a 30-day rehospitalization in 2003/2005 and in 
2007/2009 compared with those discharged from the hospital in 1999/2001 (Table 3-2). 
We observed similar results after excluding patients who were not rehospitalized but died 
during the 30-day post-discharge period. 
 
Factors associated with all-cause 30-day rehospitalizations  
Using multivariable adjusted regression analyses, we examined the role of various 
prognostic factors associated with 30-day rehospitalizations in all study patients (Table 3-
3). Female sex, a history of previously diagnosed diabetes or chronic kidney disease, 
development of in-hospital heart failure and a STEMI, and increased hospital length of 
stay were significantly associated with an increased odds of being rehospitalized for any 
reason within 30 days after hospital discharge. On the other hand, patients who received 
various coronary diagnostic and interventional procedures (cardiac catheterization and 
PCI or/and CABG) had a reduced odds for being rehospitalized within 30 days after 
hospital discharge compared with those who did not undergo these procedures (Table 3-
3). Similar factors (with the exception of diabetes) were significantly associated with 30-
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day rehospitalizations after excluding patients who were not rehospitalized but died 
during the 30-day post-discharge period. 
When we examined factors associated with 30-day rehospitalization in the most 
recently discharged patient cohort (2007/2009), patients who developed heart failure 
during their index hospiatlization were at increased odds, while those who received 
various coronary diagnostic and interventional procedures had a reduced odds, for being 
rehospitalized during the following month after hospital discharge. 
 
3.4 Discussion 
The results of this large observational study suggest that, among greater 
Worcester residents who survived hospitalization for an AMI at the three major medical 
centers in central MA between 1999 and 2009, nearly 1 in 5 patients remained at risk for 
being rehospitalized within 30 days and 38% of all 30-day rehospitalizations occurred 
during the first week after hospital discharge during the years under study. Our findings 
suggest a slight decline in the odds of being rehospitalized during the first 30 days after 
hospital discharge over time though this odds was slightly attenuated after further 
adjustment for hospital treatment practices. In addition, we identified several 
demographic and clinical factors associated with an increased odds for  being 
rehospitalized during the first month after hospital discharge for AMI  that included 
female sex, having previously diagnosed diabetes and chronic kidney disease, in-hospital 
heart failure, and having a STEMI.  
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Trends in, and magnitude of, 30-day rehospitalization rates 
Reducing hospital readmissions is a national priority to improve the quality of 
patient care and lower healthcare spending.9,29,68 This is because excess hospital 
readmissions indicate potentially poor health care quality or inadequate coordination of 
post-discharge care, represent a significant burden to both patients and the healthcare 
system, and are costly.9,29,68         
Several prior studies have examined 30-day rehospitalization rates after 
AMI.8,32,62 Between 2007 and 2009, nearly 1 in every 5 Medicare fee-for-service patients 
discharged from all acute care hospitals in the U.S. after AMI was readmitted within 30 
days after hospital discharge.8 In a recent study utilizing an all-payer administrative 
dataset from California, which consisted of 107,256  hospitalizations for AMI among 
adults less than 65 years old  between 2007 and 2009, the 30-day rehospitalization rate 
was 15%.62 A retrospective cohort study32 conducted in 3 hospitals in Olmsted County, 
MN, from 1987 to 2010 found that the 30-day readmission rates among adult patients 
who survived their hospitalization for a first AMI were approximately 23% during the 
period 1987 to 1992, 22% between 1993 and 1998, 22% between 1999 and 2004, and 
19% during the most recent 5 year period under study (2005 to 2010). In our study, we 
found similar results in that nearly one fifth of adult greater Worcester residents who 
survived their hospitalization for an AMI on a biennial basis between 1999 and 2009 
were readmitted to the hospital within 30 days after hospital discharge. In addition, 
consistent with the results of the Olmsted County, MN, study,32  our findings suggested 
no significant changes in the odds of  having a 30-day rehospitalization during the years 
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under study  after adjustment for several potentially confounding variables of prognostic 
importance.  
Since June, 2009, the Centers for Medicare and Medicaid Services (CMS) began 
publicly reporting 30-day risk-standardized readmission rates for AMI as one of the 
major hospital performance measures.29 Furthermore, the Patient Protection Affordable 
Care Act of 2010, through the establishment of the Medicare Hospital Readmissions 
Reduction Program (HRRP), has created new financial incentives to reduce readmissions 
because hospitals with excess readmissions can lose up to 3% of their Medicare 
reimbursement by 2015.9 Although some early evidence suggests that the Medicare 
HRRP has had a positive impact on reducing the rates of 30-day rehospitalization among 
Medicare beneficiaries,69 there remains no clear consensus on how many hospital 
readmissions may in all actuality be preventable. Moreover, there are also concerns about 
potential flaws in the methodology for determining excess readmissions and computation 
of the penalty to hospitals.68 Thus, it remains of considerable public health and clinical 
importance to continue monitoring changing trends in 30-day rehospitalization rates after 
AMI given ongoing refinement of the methodological approach by CMS. 
With regards to the timing of hospital readmissions, a recent study which 
analyzed Medicare fee-for-service claims data (2007-2009) on 30-day readmissions after 
hospitalization for AMI showed that approximately 40% of all 30-day readmissions 
occurred during the first week after hospital discharge.8 Another recent study using 
2007–2009 administrative data from the state of California found that 19% of 
readmissions occurred within 0–3 days, and 21% occurred during 4–7 days, after hospital 
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discharge for AMI.62 Similar to these results, our study found that 38% of all 30-day 
rehospitalizations occurred during the first week after hospital discharge for AMI. These 
findings suggest that proper arrangement of transitional care, and continuing follow up 
with patients during the first several days to first week post hospital discharge, can be 
beneficial in reducing 30-day readmission rates among these patients. Encouragingly, we 
also observed a decline in the proportion of patients who were readmitted during this 
particularly high risk period during the years under study which may suggest that efforts 
at reducing hospital readmissions may be paying dividends in reducing short-term 
hospital readmissions. 
 
Causes and predictors for 30-day rehospitalizations 
A retrospective cohort study of adult patients in Olmsted County, MN32 who were 
discharged from the hospital after a first AMI found that 43% of 30-day 
rehospitalizations after AMI were related to the incident AMI, 30% were unrelated, and 
27% had an unclear relationship. The investigators also reported that about 8% of all 30-
day rehospitalizations were due to a recurrent AMI.32 A recent study of Medicare fee-for-
service beneficiaries hospitalized for AMI at all acute care hospitals in the U.S. between 
2007 and 2009 showed that 10% of patients were readmitted for the same condition after 
their index AMI hospitalization.8 We observed similar results in that nearly 10% of all 
30-day rehospitalizations were due to AMI, and a significant proportion (37%) of all 30-
day rehospitalizations was non-CVD related. As the prevalence of comorbid conditions 
and aging of the American population increase over time, and efforts continue to be 
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focused on the enhanced use of effective secondary prevention strategies to improve the 
post-discharge outcomes of patients with AMI, 30-day rehospitalizations after AMI due 
to non-CVD causes need further attention.        
For example, recent research has suggested that patients discharged from the 
hospital may be vulnerable to “post-hospitalization syndrome,” which puts them at risk 
for rehospitalization for conditions unrelated to their initial hospitalization.70 Further 
research is needed to confirm the association between this syndrome and other hospital 
and post-discharge factors that may place patients at risk for non-CVD related hospital 
readmissions, and identify effective strategies for reducing readmissions. 
Although efforts remain ongoing to find strategies that hospitals can employ to 
prevent many readmissions, there is an ongoing debate on whether the hospital is the 
appropriate entity to be held accountable for all readmissions, particularly when many of 
the events and circumstances that are associated with readmission may take place outside 
of the hospital setting and after the administration of effective acute care. These factors 
include patients’ lifestyle behaviors and practices, employment, marital, and financial 
status, adherence to discharge instructions and medications, and the availability and 
quality of post-discharge care. Thus, reducing the frequency of hospital readmissions 
requires considerable collaborations, not only from hospitals, but also from patients and 
their caregivers and other community professionals and providers across the continuum 
of health.     
Due to ongoing and planned changes in national reimbursement policies,9 there 
has been great interest from healthcare providers to better understand and improve 
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modifiable factors associated with 30-day rehospitalizations. A recent study in Olmsted 
County, MN examined factors associated with 30-day rehospitalizations after  an incident 
AMI.32 The investigators found that certain comorbid conditions (i.e., diabetes, anemia, 
COPD), a longer hospital stay, and complications of coronary angiography and 
revascularization or reperfusion were associated with an increased risk of being 
rehospitalized.32 Our study also observed similar results in that patients with a history of 
previously diagnosed diabetes and chronic kidney disease, development of in-hospital 
heart failure, and increased hospital length of stay were significantly associated with an 
increased odds of being rehospitalized during the first month after hospital discharge for 
an AMI. Although most of these factors are not modifiable, these findings suggest that 
healthcare providers should pay extra attention to these high risk groups of patients to 
prevent potential early readmissions when planning hospital discharge and post discharge 
management.  
Despite the potential for confounding by indication given the nonrandomized 
nature of the present investigation, our multivariable regression analyses adjusting for the 
use of various hospital treatment practices showed that the use of invasive coronary 
interventions was associated with a reduced odds of being rehospitalized among patients 
hospitalized with AMI during the decade-long period under study. Furthermore, 
encouraging declines in 30 day rehospitalizations during the years under study were 
attenuated after adjustment for hospital treatment practices, suggesting the beneficial 
effects of various cardiac medications on 30 day readmission rates. A recent study 
examining rehospitalizations after an acute coronary syndrome among 5,219 patients 
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enrolled in the Australian and New Zealand populations of the Global Registry of Acute 
Coronary Events (GRACE) between 1999 and 2007 also observed similar results in that 
hospital revascularization was associated with a reduced odds of being rehospitalized 
during the next month.71  
To date, interventions designed to reduce readmission after hospitalization for 
AMI have primarily focused on improving transitional care from the hospital back to the 
community. However, few studies have specifically examined the impact of transitional 
care strategies on 30-day readmission.72 A recent analysis of data from the CRUSADE 
Registry of 25,872 older (≥65 years of age) patients with NSTEMI in 228 hospitals from 
2003 to 2006 found wide variation among hospitals in early physician follow-up (i.e., a 
physician visit within 7 days after discharge) and hospitals with higher early follow-up 
rates did not have lower 30-day readmission rates.73 Future studies examining the post-
discharge transitions of care in higher-risk patients, including those with multiple 
comorbid conditions and hospital clinical complications, remain needed to achieve 
greater declines in 30-day rehospitalizations in this patient population.  
 
Study strengths and limitations 
The strengths of the present study include its large population of residents of all 
ages and both sexes from a major central MA metropolitan area who were hospitalized 
with a confirmed AMI and examination of relatively contemporary decade-long trends in 
30-day rehospitalization rates among hospital survivors of an AMI. Several limitations 
need to be acknowledged, however, in the interpretation of the present findings. Since our 
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study population included only patients who had been hospitalized and discharged at two 
central MA medical centers, one needs to be careful in extrapolating our findings to those 
who reside in other geographic areas. If a rehospitalization occurred outside of the 
Worcester metropolitan area, it was not captured. Since study patients were 
predominantly white, the generalizability of our findings to other race/ethnic groups may 
be limited. There is also the potential for unmeasured confounding in our observed 
associations since we did not have information available on several patient-associated 
characteristics, such as income, education, psychosocial factors, and treatment preference 
which may have affected the outcomes examined. We were unable to collect information 
on other factors that have been shown to affect 30-day rehospitalization after AMI, 
including transitions of care and patients’ adherence to various post-discharge treatment 
regimens. Finally, since our study included patients hospitalized for AMI between 1999 
and 2009, future studies remain warranted to evaluate  possible changes in 30-day 
rehospitalization rates after public reporting of 30-day risk-standardized readmission 
rates initiated in 2009 and the implement of financial penalties to hospitals due to excess 
readmissions in 2012.9,29 
 
Conclusions 
The results of this large observational investigation provide insights into trends 
and causes of 30-day rehospitalizations, and factors associated with an increased risk of 
30-day rehospitalizations, among patients who survived hospitalization for an AMI 
between 1999 and 2009. The likelihood of subsequent rehospitalizations during the 
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following month remained frequent. Although most of the identified risk factors were not 
modifiable, our findings can hopefully lead to better development of innovative, patient-
centered, intervention strategies which can improve in-hospital management and follow-
up care that will further reduce the 30-day rehospitalization rates of patients discharged 
from the hospital after an AMI 
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Table 3-1 Characteristics of patients who survived an acute myocardial infarction (AMI): Worcester Heart Attack 
Study, 1999-2009 
 
  
1999/2001 
(n=1,737) 
2003/2005 
(n=1,719) 
2007/2009 
(n=1,455) 
P-value* P for trend† 
Age (mean, years) 70.2 70.5 66.6 <0.001 <.0001 
Age (%, years) 
   
<0.001 
 
<55 16.6 15.8 22.0 
  
55-64 16.9 18.7 22.0 
  
65-74 22.0 20.5 21.3 
  
75-84 28.3 26.7 25.4 
  
85+ 16.1 18.3 9.3 
  
Female, % 41.2 44.0 40.5 0.10 0.76 
White, % 94.7 92.7 92.0 0.007 0.003 
Married, % 57.2 52.1 56.1 0.009 0.44 
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Hospital length of stay (mean, days) 6.7 5.6 4.9 <0.001 <.0001 
Medical history 
     
Angina, % 22.6 18.9 7.7 <0.001 <0.001 
Atrial fibrillation, % 13.1 13.2 13.3 0.99 0.91 
Heart failure, % 22.5 24.4 21.1 0.09 0.42 
Hypertension, % 67.4 74.6 74.8 <.0001 <.0001 
Peripheral vascular disease, % 12.2 18.7 18.8 <.0001 <.0001 
Stroke, % 11.6 11.2 10.5 0.61 0.32 
Diabetes, % 31.7 33.9 34.6 0.18 0.08 
Chronic obstructive pulmonary disease, % 16.7 17.7 16.8 0.70 0.92 
Depression, % 11.1 17.6 18.6 <.0001 <.0001 
Chronic kidney disease, % 12.0 19.4 23.1 <.0001 <.0001 
ST-segment myocardial infarction, % 41.7 32.8 30.7 <.0001 <.0001 
Initial myocardial infarction, % 64.8 64.8 64.0 0.86 0.63 
In-hospital clinical complications 
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Atrial fibrillation, % 17.8 21.1 17.0 0.006 0.67 
Cardiogenic shock, % 3.6 3.0 3.6 0.60 0.96 
Stroke, % 1.5 1.3 1.0 0.51 0.25 
Heart failure, % 35.6 36.9 33.2 0.09 0.18 
Physiological factors on hospital admission 
     
Initial heart rate (mean, beats/min) 86.0 85.9 83.7 0.003 0.002 
Systolic blood pressure (mean, mmHg)  144.7 143.9 140.6 0.001 <0.001 
Diastolic blood pressure (mean, mmHg) 78.6 77.1 78.2 0.06 0.51 
Serum glucose (mean, mg/dL) 169.8 170.3 162.0 0.004 0.005 
Estimated glomerular filtration rate (mean,  
mL/min per 1.73 m2) 
60.9 59.6 57.0 <.0001 <.0001 
 
* P-values derived from ANOVA tests for continuous variables and chi-square tests for categorical variables.  
† P-values derived from Cochran-Armitage tests for categorical variables and linear regression models for continuous 
variables.  
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Table 3-2 Association between time period of hospitalization and 30-day all-cause rehospitalizations among patients 
who survived an acute myocardial infarction (AMI): Worcester Heart Attack Study, 1999-2009 
 
 
Frequency of  
30-day 
rehospitalization  
Adjusted for 
sociodemographics 
and comorbidities* 
Further adjusted 
for in-hospital 
factors† 
Further adjusted 
for in-hospital 
management‡ 
Further adjusted 
for discharge 
medications§ 
Study Period %   Adjusted OR (95% CI) 
1999-2001 20.3 1.00 1.00 1.00 1.00 
2003-2005  19.9 0.91 (0.69-1.19) 0.93 (0.69-1.24) 0.99 (0.73-1.34) 0.98 (0.71-1.36) 
2007-2009  16.7 0.76 (0.61-0.94) 0.79 (0.62-1.00) 0.86 (0.67-1.09) 0.85 (0.66-1.10) 
OR: odds ratios (OR); CI: confidence intervals  
* Adjusted for age, sex, race, marital status, and previously diagnosed comorbid conditions. 
† Adjusted for sociodemographics, comorbid conditions, AMI order, AMI type, in-hospital complications, and hospital length 
of stay.  
‡ Adjusted for sociodemographics, comorbid conditions, in-hospital factors, and in-hospital management as represented by 
thrombolytic therapy and receipt of 3 coronary interventional procedures (cardiac catheterization, PCI, and CABG).  
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§Adjusted for sociodemographics, comorbid conditions, in-hospital factors, in-hospital management, and prescribing of 4 
guideline-recommended cardiac medications (ACE-I/ARBs, lipid lowering agents, beta blockers, and aspirin) at the time of 
hospital discharge. 
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Table 3-3 Association between various prognostic factors and 30-day all-cause rehospitalizations among patients who 
survived an acute myocardial infarction (AMI): Worcester Heart Attack Study, 1999-2009 
 
 
Adjusted for 
sociodemographics 
and comorbidities* 
Further adjusted 
for in-hospital 
factors† 
Further adjusted 
for in-hospital 
management‡ 
Further adjusted 
for discharge 
medications§ 
Factors   Adjusted OR (95% CI) 
Age <55 1.00 1.00 1.00 1.00 
Age 55-64 1.17 (0.68-2.01) 1.12 (0.66-1.90) 1.11 (0.66-1.87) 1.11 (0.66-1.86) 
Age 65-74 1.31 (0.88-1.96) 1.19 (0.83-1.72) 1.17 (0.81-1.68) 1.17 (0.83-1.66) 
Age 75-84 1.62 (1.01-2.60) 1.46 (0.92-2.33) 1.38 (0.89-2.15) 1.38 (0.89-2.16) 
Age 85+ 1.27 (0.67-2.42) 1.14 (0.62-2.08) 1.00 (0.56-1.79) 1.00 (0.56-1.80) 
Female (vs. Male) 1.25 (1.09-1.43) 1.26 (1.11-1.44) 1.24 (1.09-1.42) 1.24 (1.09-1.42) 
White (vs. non-White) 0.76 (0.49-1.16) 0.75 (0.46-1.21) 0.76 (0.47-1.24) 0.76 (0.46-1.24) 
Married (vs. not Married) 1.08 (0.87-1.33) 1.09 (0.89-1.32) 1.10 (0.90-1.34) 1.10 (0.91-1.34) 
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Comorbidity      
Angina 1.10 (0.92-1.32) 1.09 (0.92-1.30) 1.11 (0.93-1.33) 1.11 (0.92-1.33) 
Atrial fibrillation  1.28 (0.99-1.65) 1.21 (0.87-1.67) 1.19 (0.87-1.61) 1.19 (0.88-1.62) 
Heart failure  1.38 (1.14-1.69) 1.24 (1.00-1.53) 1.20 (0.97-1.48) 1.20 (0.97-1.48) 
Hypertension  0.91 (0.76-1.07) 0.91 (0.77-1.07) 0.92 (0.78-1.08) 0.92 (0.78-1.09) 
Peripheral vascular disease  1.15 (0.85-1.54) 1.12 (0.83-1.50) 1.13 (0.85-1.49) 1.13 (0.86-1.49) 
Stroke  1.07 (0.76-1.51) 1.08 (0.76-1.53) 1.05 (0.74-1.48) 1.05 (0.74-1.48) 
Diabetes  1.20 (1.04-1.39) 1.16 (1.00-1.33) 1.15 (1.01-1.32) 1.15 (1.00-1.32) 
Chronic obstructive pulmonary disease  1.12 (0.94-1.35) 1.08 (0.88-1.32) 1.06 (0.88-1.27) 1.06 (0.88-1.27) 
Depression  1.08 (0.89-1.32) 1.09 (0.88-1.35) 1.08 (0.88-1.33) 1.08 (0.88-1.34) 
Chronic kidney disease  1.52 (1.19-1.95) 1.45 (1.13-1.86) 1.40 (1.11-1.77) 1.40 (1.12-1.74) 
Initial AMI (vs. Prior AMI)  0.89 (0.76-1.04) 0.89 (0.76-1.04) 0.90 (0.77-1.04) 
ST-segment myocardial infarction   1.12 (0.98-1.28) 1.17 (1.01-1.35) 1.17 (1.01-1.36) 
Hospital Length of Stay (per day)  1.01 (1.00-1.03) 1.02 (1.00-1.03) 1.02 (1.00-1.03) 
In-hospital clinical complication     
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Atrial fibrillation   1.20 (0.87-1.65) 1.20 (0.87-1.65) 1.20 (0.88-1.65) 
Cardiogenic shock   1.23 (0.84-1.80) 1.28 (0.90-1.84) 1.28 (0.87-1.87) 
Stroke   0.71 (0.25-2.01) 0.68 (0.24-1.93) 0.70 (0.26-1.89) 
Heart failure   1.39 (1.20-1.61) 1.36 (1.18-1.57) 1.36 (1.18-1.57) 
Coronary diagnostic/interventional 
procedure 
    
No coronary procedure   
 
1.00 1.00 
Cardiac catheterization   
 
0.80 (0.62-1.04) 0.79 (0.60-1.04) 
Cardiac catheterization and PCI and/or  
CABG 
 
 
0.75 (0.61-0.91) 0.74 (0.60-0.91) 
Thrombolytic therapy  
 
1.03 (0.65-1.62) 1.03 (0.65-1.62) 
Medication at hospital discharge     
ACEI/ARBs   
 
 0.99 (0.73-1.34) 
Aspirins   
 
 1.11 (0.85-1.45) 
Beta blockers   
 
 0.99 (0.80-1.24) 
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Lipid-lowering agents   
 
 1.01 (0.80-1.28) 
OR: odds ratios (OR); CI: confidence intervals  
* Adjusted for study period, sociodemographics, and comorbidities. 
† Adjusted for study period, sociodemographics, comorbid conditions, AMI order, AMI type, in-hospital clinical 
complications, and hospital length of stay.  
‡ Adjusted for study period, sociodemographics, comorbid conditions, in-hospital factors, and in-hospital management as 
represented by thrombolytic therapy and receipt of 3 coronary interventional procedures (cardiac catheterization, PCI, and 
CABG).  
§Adjusted for study period, sociodemographics, comorbid conditions, in-hospital factors, in-hospital management, and 
prescribing of 4 guideline-recommended cardiac medications (ACE-I/ARBs, lipid lowering agents, beta blockers, and aspirin) 
at the time of hospital discharge 
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Figure 3-1 Rates of rehospitalizations within 30 days after hospital discharge among 
patients who survived an acute myocardial infarction (AMI): Worcester Heart 
Attack Study, 1999-2009 
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Figure 3-2 Cause-specific 30-day rehospitalization rates after hospital discharge 
among patients who survived an acute myocardial infarction (AMI): Worcester 
Heart Attack Study, 1999-2009 
 
 
*CVD: Cardiovascular diseases exclude AMI 
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CHAPTER 4 : A 35-YEAR PERSPECTIVE (1975-2009) INTO 
THE LONG-TERM PROGNOSIS AND HOSPITAL 
MANAGEMENT OF PATIENTS DISCHARGED FROM THE 
HOSPITAL AFTER A FIRST ACUTE MYOCARDIAL 
INFARCTION 
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Abstract 
Background 
There are limited population-based data available describing trends in the long-term 
prognosis of patients discharged from the hospital after an initial acute myocardial 
infarction (AMI). Our objectives were to describe multi-decade (1975-2009) trends in 
post-discharge mortality, and their association with hospital management practices, 
among patients discharged from all central Massachusetts medical centers after a first 
AMI.  
Methods 
Residents of the Worcester, MA, metropolitan area discharged from 11 central 
Massachusetts  hospitals after a first AMI between 1975 and 2009 comprised the study 
population (n=8,728). Multivariable-adjusted logistic regression analyses were used to 
examine the association between year of hospitalization and 1-year post-discharge 
mortality.  
Results 
The average age of this population was 66 years and 40% were women. Patients 
hospitalized in 1999-2009, as compared with those discharged in 1975-1984, were older, 
more likely to be women, and have multiple previously-diagnosed comorbidities. 
Hospital use of invasive cardiac interventions and medications increased markedly over 
time. Unadjusted 1-year mortality rates were 12.9%, 12.5%, and 15.8% for patients 
discharged during 1975-1984, 1986-1997, and 1999-2009, respectively. After adjusting 
for several demographic characteristics, clinical factors, and in-hospital complications, 
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there were no significant differences in the odds of dying at 1 year post-discharge during 
the years under study. After further adjustment for hospital treatment practices, the odds 
of dying at 1 year post-discharge was 2.43 (95% confidence intervals: 1.83-3.23) times 
higher in patients hospitalized in1999-2009 than in 1975-1984.  
Conclusions 
The increased use of invasive cardiac interventions and pharmacotherapies was 
associated with enhanced long-term survival among patients hospitalized for a first AMI. 
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4.1 Introduction 
Although coronary heart disease remains a leading cause of death and disability, 
and a major burden on health care systems in the U.S.,1 there have been continuous 
improvements in the in- hospital and 30-day survival of American adults hospitalized 
with acute myocardial infarction (AMI) during the past several decades.19,20,34,74 The 
encouraging increases in short-term survival among patients hospitalized with AMI are 
associated with a number of factors including improvements in the primary prevention of 
AMI, patient education, and more widespread use of coronary reperfusion and 
revascularization procedures and effective cardiac medications.75–78 Despite these 
encouraging trends in short-term survival, approximately 1 in every 7 patients discharged 
from the hospital after an AMI will die during the next year.34 Moreover, some studies 
have shown either no change over time,  or actual worsening survival, among patients 
discharged from the hospital after an AMI.34,79 
 While a limited number of studies in the U.S. have examined long-term survival 
after hospital discharge for AMI,11,34,79 data describing relatively contemporary, and 
potentially changing, trends in the post-hospital discharge mortality rates of patients after 
a first AMI are sparse.34,79 Moreover, it is unclear whether and how much changes in 
hospital treatment practices are associated with the risk of dying post-hospital discharge, 
particularly from the more generalizable perspective of a population-based investigation.  
The primary objective of our large community-based study was to examine 
changing trends in long-term prognosis among residents of central Massachusetts 
discharged from all central Massachusetts medical centers after a first AMI over an 
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approximate 35-year period (1975 - 2009). A secondary study goal was to understand 
whether, and to what extent, increases in the use of effective cardiac treatment 
approaches during the patient’s index hospitalization were associated with changes in 
long-term mortality. Data from the population-based Worcester Heart Attack Study were 
used for purposes of this investigation.3,12–15 
 
4.2 Methods 
Described elsewhere in detail,12–15 the Worcester Heart Attack Study is an 
ongoing population-based investigation describing long-term trends in the epidemiology 
of AMI in residents of the Worcester, Massachusetts,  metropolitan area (2000 census= 
478,000) hospitalized at all 16 medical centers in Central Massachusetts on an 
approximate biennial basis during 1975, 1978, 1981, 1984, 1986, 1988, 1990, 1991, 
1993, 1995, 1997, 1999, 2001, 2003, 2005, 2007, and 2009.12–15 In 2000, the median age 
of residents of the Worcester metropolitan area was 37 years, 49% were men, 89% were 
white, and approximately 25% had a bachelor’s degree or higher.15 Due to hospital 
closures, mergers, or conversion to long-term care or rehabilitation facilities, fewer 
hospitals (n=11) have been providing care to greater Worcester residents during the most 
recent years of this community-wide investigation.       
Computerized printouts of patients discharged from all greater Worcester 
hospitals with possible AMI [International Classification of Disease (ICD) 9 codes: 410-
414, 786.5] were identified. Cases of possible AMI were independently validated using 
predefined criteria for AMI;12–15 these criteria included a suggestive clinical history, 
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increases in several serum biomarkers (e.g., creatine kinase (CK), CK-MB, and troponin 
values), and serial electrocardiographic findings during hospitalization consistent with the 
presence of AMI. Patients who satisfied at least 2 of these 3 criteria, and were residents 
of the Worcester metropolitan area, were included. 
For purposes of the present study, we restricted our sample to adult residents of 
the Worcester metropolitan area who survived their index hospitalization for a first AMI 
between 1975 and 2009. Patients with an initial AMI were identified by either mention in 
the review of hospital charts that this was the patient’s first admission for an AMI or 
through the review of previous hospital records and electrocardiograms that failed to 
indicate the occurrence of a previous AMI. This study was approved by the Institutional 
Review Board at the University of Massachusetts Medical School. 
 
Data Collection 
Trained nurses and physicians abstracted information on patients’ demographic 
characteristics, medical history, clinical data, and treatment practices through the review 
of hospital medical records. These factors included patient’s socio-demographic 
characteristics (age, sex, race, marital status), year of hospitalization, hospital length of 
stay, history of previously diagnosed comorbidities (e.g., stroke, diabetes, heart failure), 
and AMI type [Q-wave vs. non-Q-wave; ST-segment elevation myocardial infarction 
(STEMI) vs. non-ST-segment elevation myocardial infarction (NSTEMI)].3,24 
Information on the development of important in-hospital complications including atrial 
fibrillation,63 cardiogenic shock,64 heart failure,65 and stroke66 was also collected. 
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Data on the receipt of thrombolytic therapy and 3 coronary diagnostic and 
interventional procedures [cardiac catheterization, percutaneous coronary intervention 
(PCI), and coronary artery bypass grafting (CABG) surgery] during hospitalization, and 
pharmacotherapies at the time of hospital discharge, including the prescribing of 6 
effective cardiac medications [angiotensin converting inhibitors (ACE-I)/angiotensin 
receptor blockers (ARBs), anticoagulants, aspirin, beta blockers, calcium channel 
blockers, and lipid lowering agents], were obtained. While we collected follow-up 
information on all study patients through 2012, we examined trends in 1-year post-
hospital discharge all-cause mortality rates. This time point was chosen since a number of 
prior investigations80,81 have shown this follow-up point to be a particularly high-risk 
period for dying among patients discharged from the hospital after an AMI. The 
approaches used to ascertain survival status after hospital discharge included a review of 
medical records for additional hospitalizations and a statewide and national search of 
death certificates for residents of the Worcester metropolitan area.   
 
Data Analysis 
For ease of analysis and interpretation, we aggregated the 17 individual study 
years into approximate 3 decade-long time periods (1975-1984, earliest; 1986-1997, 
middle; and 1999-2009, most recent) for purposes of examining changing trends in 1 year 
post-discharge mortality rates. Furthermore, these time period categorizations reflect 
major changes in the management of patients hospitalized with AMI that have occurred 
over time from the use of mainstay therapies, such as aspirin and beta blockers during the 
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earliest years under study, to the use of thrombolytic therapy in the mid-1980s, to the use 
of more aggressive and invasive interventions including PCI and lipid lowering therapy 
during the most recent decade under study. Differences in the distribution of various 
patient demographic and clinical characteristics, development of in-hospital clinical 
complications, receipt of in-hospital interventional procedures and thrombolytic therapy, 
and prescribing of cardiac medications at the time of hospital discharge between patients 
hospitalized during the 3 time periods were examined using the ANOVA test for 
continuous variables and the chi-square test for categorical variables. The Cochran-
Armitage tests and linear regression models were used to test for linear trends over time 
among categorical variables and continuous variables, respectively.  
Long-term mortality after hospital discharge was examined by calculating 1 year 
all-cause mortality rates. Multivariable-adjusted logistic regression analyses were 
performed to examine the association between the main explanatory variable of time 
period of hospitalization (1975-1984, earliest; 1986-1997, middle; and 1999-2009, most 
recent) and the outcome of 1-year post-discharge all-cause mortality (dead vs. alive) 
while adjusting for several potentially confounding variables of prognostic importance. 
Since the 3 time periods reflect changes in the management of patients hospitalized with 
AMI, and a linear relationship with the outcome of total mortality was not assumed, we 
dummy coded this variable with the earliest period (1975-1984) serving as the reference 
group. Several covariates associated with long-term mortality in patients discharged from 
the hospital after AMI in prior studies11,34,76–78 were examined sequentially in 4 blocks. 
The first block included age, sex, race (white vs. non-white), marital status (married vs. 
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not-married), and previously diagnosed comorbid conditions (i.e., angina, diabetes, heart 
failure, hypertension, and stroke). The second block included AMI type (Q-wave vs. non-
Q-wave), in-hospital clinical complications (atrial fibrillation, heart failure, cardiogenic 
shock), and hospital length of stay. The third block included in-hospital management 
practices as represented by the receipt of thrombolytic therapy and 3 coronary 
interventional procedures (e.g., cardiac catheterization, PCI, and CABG). The fourth 
block included the prescribing of 4 guideline-recommended cardiac medications (ACE-
I/ARBs, lipid lowering agents, beta blockers, and aspirin) at the time of hospital 
discharge. Based on their clinical relevance and preliminary univariate associations, all 
potential covariates were retained and fitted into multivariable logistic regression models 
by adding the blocks of variables sequentially. 
We also repeated our multivariable-adjusted logistic regression analyses restricted 
to patients hospitalized during the most recent decade under study (1999-2009) for 
purposes of providing a relatively contemporary perspective into the association between 
year of hospitalization and 1-year all-cause mortality. For this analysis, we also adjusted 
for type of AMI (STEMI and NSTEMI) since information about whether the patient’s 
ECG showed changes in ST segment elevation or otherwise was only obtained from 1999 
on. Our results were presented as multivariable adjusted odds ratios (OR) and 
accompanying 95% confidence intervals (CI), which were calculated based on standard 
errors clustered at the hospital level to account for potential within-hospital correlation 
with variance adjustment through the use of Morel’s small sample bias correction.67 All 
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statistical analyses were conducted using SAS version 9.3 (SAS Institute, Inc, Cary, 
North Carolina). 
 
4.3 Results 
Study population characteristics 
The study population consisted of 8,728 adult residents of the Worcester 
metropolitan area who survived their hospitalization for an independently confirmed first 
AMI at all central Massachusetts medical centers between 1975 and 2009 (Table 1). 
Overall, the average age of this patient population was 66.4 years, 60.0% were men, the 
majority were white (95.4%), and 61.0% were married.  
Patients discharged from all greater Worcester hospitals after a first AMI during 
recent, as compared with earlier, study years were significantly older, were more likely to 
be women, and were less likely to be married (Table 4-1). The proportion of patients with 
a Q-wave MI declined over time and, between 1999 and 2009, 40.0% of our study sample 
was diagnosed with an STEMI. 
During the most recent years under study, patients who survived their initial AMI 
were more likely to have a history of heart failure, hypertension, diabetes, or stroke than 
patients hospitalized during earlier study periods (Table 1). The proportion of patients 
with multiple (≥2) comorbid conditions increased from 24.2% in 1975-1984 to 36.6% in 
1999-2009 (p for trend <0.001). The average hospital length stay declined markedly over 
time from an average of 16.8 days in 1975-1984 to 5.5 days in 1999-2009 (Table 4-1).  
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Overall, the likelihood of developing cardiogenic shock or a  stroke during the 
patient’s index  hospitalization remained relatively low (2.7% and 1.0% overall, 
respectively) whereas the incidence rates of in-hospital heart failure and atrial fibrillation 
were considerably higher (30.5% and 15.2% overall, respectively). In general, there was 
an upward trend in the proportion of patients who developed cardiogenic shock (p for 
trend <0.0001) and atrial fibrillation (p for trend=0.0003) during their index 
hospitalization, but a downward trend in the development of acute heart failure (p for 
trend =0.043) was observed from the earliest to the most recent years under study; the 
development of acute stoke remained low and stable throughout the years under study 
(p=0.67) (Figure 4-1).  
 
Receipt of coronary procedures, thrombolytic therapy, and cardiac medications  
The use of cardiac catheterization and PCI has increased markedly over time 
whereas the proportion of patients undergoing CABG surgery during their index 
hospitalization has significantly  increased but remained relatively low during the years 
under study  (all p values for trend <0.001). The use of thrombolytic therapy increased 
during the 1990’s but markedly decreased thereafter (Figure 4-2a). Cardiac 
catheterization, PCI, CABG surgery, and thrombolytic therapy were used in 78.2%, 
60.8%, 6.7%, and 0.2% respectively, of patients who survived a first AMI in 2009 
(Figure 4-2a). 
Marked increases in the prescribing of aspirin, ACEI/ARBs, beta blockers, and 
lipid-lowering medications at the time of hospital discharge were observed during the 
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years under study (p for trend <0.001) (Figure 4-2b). On the other hand, use of calcium 
channel blockers has declined markedly during recent years (p for trend <0.001). The use 
of anticoagulants among patients who survived a first AMI increased through the mid-
1990’s, declined in the late 1990’s, and remained stable during the 2000’s (Figure 4-2b). 
Aspirin, ACEI/ARBs, beta blockers, and lipid-lowering medications were prescribed at 
the time of hospital discharge in 94.0%, 64.4%, 90.7%, and 90.1% of patients who 
survived a first AMI in 2009. 
 
Post-hospital discharge 1-year all-cause mortality rates  
The overall (1975-2009) all-cause death rates for patients who survived a first 
AMI were 13.9% at 1 year after hospital discharge. The average 1-year all-cause 
mortality rates remained relatively stable from 1975-1984 (12.9%) to 1986-1997 
(12.5%), but increased during 1999-2009 (15.8%).  
In examining changing trends in all-cause mortality during the first year after 
hospital discharge, our unadjusted analyses showed that, compared with patients 
surviving an initial AMI in 1975-1984, there were no significant differences in the odds 
of dying at 1 year post discharge among patients discharged from all central MA medic al 
centers after a first AMI  in 1986-1997 (OR=0.96, 95% CI=0.64-1.45) and in 1999-2009 
(OR=1.27, 95% CI=0.80-2.02) (Table 4-2).      
After  sequentially adjusting for several demographic characteristics, clinical 
factors, and in-hospital clinical complications, there were no significant differences in the 
odds of dying at 1 year post discharge among patients discharged from all metropolitan 
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Worcester  hospitals in 1986-1997 (OR=0.80, 95% CI=0.60-1.08) and 1999-2009 
(OR=0.82, 95% CI=0.59-1.15), compared with those hospitalized in 1975-1984. 
However, after further adjustment for medical treatment during hospitalization, and the 
prescribing of evidence-based medications at hospital discharge, there was a borderline 
significant trend (p=0.08) toward an increased risk of dying at 1 year post discharge 
among patients hospitalized in 1986-1997; the odds of dying from all causes at 1 year 
post discharge was approximately 2.4 times higher in patients discharged from the 
hospital in 1999-2009 compared with those discharged during 1975-1984 (Table 4-2). 
We repeated these crude and multivariable adjusted analyses in patients who were 
hospitalized during the most recent decade under study (1999-2009) to reflect more 
recent trends in long-term prognosis. The unadjusted analyses showed that, compared 
with patients discharged after an initial AMI  in 1999/2001 (referent group), there was no 
significant difference in the odds of dying at 1 year post discharge among patients 
hospitalized in 2003/2005 and in 2007/2009 (Table 4-2). After controlling for several 
demographic characteristics, clinical factors, and in-hospital complications, the odds of 
dying at 1 year post discharge was significantly decreased among patients hospitalized in 
2003/2005 (OR=0.68, 95% CI=0.48-0.97) and 2007/2009 (OR=0.62, 95% CI=0.47-0.83), 
compared with those hospitalized in 1999/2001. However, after further adjustment for the 
receipt of medical interventions during hospitalization, and the prescribing of evidence-
based medication at the time of  hospital discharge, there was no significant difference in 
the odds of dying at 1 year post discharge among patients hospitalized in 2003/2005 and 
in 2007/2009, in comparison with those hospitalized in 1999/2001 (Table 4-2). 
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4.4 Discussion 
The results of this community-wide study suggest that there have been 
considerable changes in the demographic, clinical, and treatment profile of greater 
Worcester residents who survived hospitalization for a first AMI at all central 
Massachusetts medical centers between 1975 and 2009. The hospital use of invasive 
coronary interventions and effective cardiac medications increased markedly over time. 
The average post-discharge 1-year all-cause mortality rates remained relatively stable 
from 1975-1984 to 1986-1997, but increased slightly during 1999-2009. Using 
multivariable-adjusted regression analyses, after adjustment for demographic 
characteristics, clinical factors, and in-hospital complications, no significant differences 
in the odds of dying at 1 year after hospital discharge were observed during the years 
under study. Once we adjusted for the receipt of various hospital treatment practices 
during hospitalization, however, the odds of dying at 1 year post discharge among 
patients hospitalized during the most recent years under study actually increased, 
suggesting the beneficial impact of these treatment modalities on the long-term prognosis 
of discharged patients.  
 
Changing profile of hospital survivors after a first AMI 
Consistent with the findings from a prior population-based study conducted at 
nonfederal acute care hospitals in New Jersey,34 we found that residents of the Worcester 
metropolitan area who survived their hospitalization for a first AMI during the most 
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recent years under study were significantly older, were more likely to be women, and  
had multiple comorbidities previously diagnosed than patients who were hospitalized 
during earlier study years.   
Prior studies have suggested that reductions  in the primary risk factors for 
coronary heart disease (e.g., smoking, blood lipids, and blood pressure) and 
improvements in the management of patients with acute coronary disease  account for the 
majority of the decline in CHD mortality and incidence observed in developed countries 
during the past several decades.75,82 Although only speculative, several factors may have 
contributed to delaying the onset of a first AMI to an older age as observed in our 
investigation. These factors include the healthier aging of the American population, 
improvements in the medical and clinical management of patients with pre-existing 
coronary disease, and the increasing adoption of healthy lifestyle practices and other 
primary preventive modalities in the general population and in various at-risk groups. 
However, it is worth noting that survivors of a first AMI during our  most recent study 
years (1999-2009) were much more likely to have had diabetes previously diagnosed 
compared with those hospitalized during the earliest years under study (1975-1984). 
These trends likely reflect the ongoing epidemic of obesity and diabetes in the U.S.1  
The current trends of increasing age and prevalence of multiple comorbidities in 
patients hospitalized with a first AMI present significant challenges to healthcare 
providers involved in the management of these high risk patients. Indeed, several 
population-based investigations, including our own, have demonstrated that, compared 
with younger patients hospitalized with AMI, older patients are more likely to develop 
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important hospital clinical complications and have a worse in-hospital and long-term 
survival.20,34,83,84 Previous studies have also demonstrated a poorer long-term prognosis 
for patients hospitalized with AMI who had previously diagnosed comorbidities, such as 
diabetes, heart failure, and stroke.11,34,85 Therefore, continued surveillance remains 
needed to monitor these and other ongoing trends in patients hospitalized with a first 
AMI in central Massachusetts  as well as in other geographic settings throughout the U.S.   
 
Post-hospital discharge mortality rates and hospital treatment practices  
Although several population-based studies34,79 have reported encouraging declines 
in the in-hospital and 30 day mortality rates in patients hospitalized with a first AMI, 
there are data to suggest that favorable short-term trends in mortality may not extend to 
patient’s  long-term prognosis after hospital discharge.34,79 The current investigation and 
several prior studies34,79 have shown that the 1 year death  rate among patients discharged 
after a first AMI remains relatively high, emphasizing the need for continued surveillance 
and optimization of the medical care of these patients. 
Our study showed that the unadjusted 1-year all-cause mortality rates among 
patients discharged from all central Massachusetts medical centers after a first AMI have 
actually increased in the most recently hospitalized patient cohort (1999-2009), which 
likely reflects the increasingly older patient population with a greater prevalence of 
multiple comorbidities. A previously published study of more than 285,000  patients 
hospitalized with a first AMI at nonfederal acute care hospitals in New Jersey between 
1986 and 2007 found that the 1-year post-discharge mortality rates also increased over 
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time, from 12.1% in 1986 to 13.9% in 2007;34 the increased risk of dying over time  was  
most evident in the oldest patients  and were primarily due to non-cardiovascular causes 
of death.34 In a study of  2,816 residents of Olmsted County, MN, hospitalized with an 
incident AMI between 1987 and 2006, there were no changes in 1 year post-discharge 
mortality during the years under study.79 
These findings suggest that improving the long-term outcomes of patients 
discharged from the hospital after a first AMI will likely require expanding the use of 
existing, and novel, preventive and/or therapeutic strategies in these patients after 
hospital discharge, and these treatment plans need to take into account the age and 
presence of other comorbid conditions in these patients. To effectively implement these 
strategies, collaboration of care management between patients and their providers, and 
strong partnership between cardiologists and primary care physicians, remain crucial to 
the success of effective post-discharge care transitions. 
Consistent with the results of several population-based investigations, we showed 
that the use of coronary interventional procedures and effective  cardiac medications has 
increased markedly over the past several decades.19,20,25 Despite the potential for 
confounding by indication given the nonrandomized nature of the present community-
based investigation, our multivariable regression analyses adjusting for the use of various 
hospital treatment practices showed that the increased use of invasive interventions and 
evidence-based pharmacotherapies was associated with increased post discharge survival 
among patients hospitalized for a first AMI during the most recent decade under study. 
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Several prior studies have used similar multivariable regression analyses to 
examine the effects of hospital treatment practices on patient’s long-term prognosis.77,78 
In a study of 4,451 patients aged 35-64 years with a first AMI from the population-based 
Perth MONICA (Multinational MONItoring of trends and determinants in 
CArdiovascular disease) cohort (1984-2005), improving trends in 1 year and longer 
survival were observed and were associated with an increased use of evidence-based 
treatments during hospitalization and in the 12 months after the index event.78 A recent 
population-based study examined the use of treatment approaches and outcomes in a 
random sample of 1,226 patients 75 years and older who were hospitalized for AMI in 
Minneapolis/St. Paul, and Goteborg, Sweden in 2001-2002. The investigators 
demonstrated that the use of PCI was markedly higher in Minneapolis/St. Paul than in 
Goteborg, and the long-term survival at 1, 3, and 5 years was greater among elderly 
patients in Minneapolis/St. Paul compared with those from Goteborg, Sweden, likely 
related to the greater utilization of PCI.77 
Although clinical trials remain the gold standard for examining treatment 
efficacy, data from observational studies can provide important complementary insights 
into the effectiveness of treatments in the broader community setting. These studies, 
however, have several limitations including the lack of data on patients’ post-discharge 
cognitive status, changes in healthy lifestyle practices, and long-term adherence to 
evidence-based treatment after hospital discharge for AMI. Current data suggests  less 
than optimal patient adherence to evidence-based therapies after AMI,86 and non-
adherence to these effective medications has been associated with an increased risk of 
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cardiovascular mortality.87 Inasmuch, ongoing dialogues between patients and their 
providers about the importance of adhering to effective secondary prevention approaches 
on a long-term basis remain important. Future studies examining the increasing use of 
conventional and more novel treatment strategies, and post-discharge transitions of care, 
in higher-risk patients, including the elderly and those with multiple comorbid conditions, 
remain needed to achieve greater declines in long-term mortality in this patient 
population. 
 
Study strengths and imitations 
The strengths of the present study include its community-based design and 
examination of multiple decade long trends in long-term mortality rates and hospital 
treatment practices among hospital survivors of an initial AMI. Several limitations need 
to be acknowledged, however, in the interpretation of the present findings. First, since 
our study only included patients who had been hospitalized for an initial AMI at all 
central Massachusetts medical centers, one needs to be careful in extrapolating our 
findings to persons who died before hospitalization, or to those who reside in other 
geographic areas. Second, since our study patients were predominantly white, the 
generalizability of our findings to other race/ethnic groups may be limited. Our study 
examined pharmacotherapies prescribed at the time of hospital discharge. However, 
patients might have been prescribed these medications as outpatients. Lastly, there is the 
potential for unmeasured confounding in our observed associations since we did not have 
information available on several patient-associated characteristics, such as income, 
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education, psychological factors, and treatment preference,  and we were unable to 
collect information on other factors that have been shown to affect long-term prognosis 
after AMI, including the severity of the AMI, and patients’ adherence to various post-
discharge treatment regimens after being discharged from the hospital after a first AMI. 
 
Conclusions 
The results of this community-wide investigation provide insights into the 
changing characteristics, management practices, and long-term prognosis of patients who 
survived hospitalization for a first AMI over a 35-year period of investigation. The 
increased use of invasive cardiac interventions and pharmacotherapies during the 
patient’s index hospitalization was associated with a reduced risk for dying at 1 year in 
this patient population based on observed mortality findings after adjustment for these 
treatment approaches. Our findings reinforce the importance of expanding the scope of 
care from the acute treatment of AMI to effective post-discharge care management 
strategies, including education of the patient’s caregivers, to improve the long-term 
outlook of patients after a first AMI. Future studies examining the impact of individual 
and combined evidence-based treatments on patient’s long-term survival, and the effects 
of medication adherence on endpoints of clinical and public health importance, including 
hospital readmissions, the development of recurrent coronary events, and quality of life 
remain warranted.  
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Table 4-1 Characteristics of patients who survived a first acute myocardial infarction (AMI) according to time period 
of hospitalization: Worcester Heart Attack Study, 1975-2009 
 
 
1975-1984 1986-1997 1999-2009 
  (n=1,820) (n=3,407) (n=3,501) 
Age (mean, years) 63.8 66.3 67.9 
Age (%, years) 
   
<55 24.7 21.0 21.5 
55-64 27.8 20.7 19.9 
65-74 15.5 21.9 25.1 
75-84 15.5 21.9 25.1 
≥85 6.2 8.4 13.4 
Male (%) 64.3 59.5 58.2 
White (%) 97.2 96.1 93.7 
Married (%) 67.1 62.2 56.6 
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ST-segment myocardial infarction (%) N/A N/A 40.0 
Q-wave (%) 64.7 51.3 27.6 
Hospital length of stay (mean, days) 16.8 9.5 5.5 
    
Medical History (%) 
   
Angina 18.4 19.0 12.8 
Heart failure  6.5 7.8 13.8 
Hypertension 44.1 51.7 65.5 
Stroke 4.6 6.7 8.3 
Diabetes 18.5 23.2 27.1 
 
* P-values derived from ANOVA tests for continuous variables and chi-square tests for categorical variables were all <0.001.  
**P-values derived from Cochran-Armitage tests for categorical variables and linear regression models for continuous 
variables were all <0.001. 
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Table 4-2 Crude and multivariable adjusted odds of dying at 1-year after hospital discharge for patients who survived 
a first acute myocardial infarction (AMI): Worcester Heart Attack Study, 1975-2009 
 
 
Unadjusted 
Adjusted for 
sociodemographics 
and comorbidities* 
Further adjusted 
for in-hospital 
factors† 
Further adjusted 
for in-hospital 
management‡ 
Further adjusted 
for discharge 
medications§ 
  Crude OR (95% CI) Adjusted OR (95% CI) 
1975-1984 1.00 1.00 1.00 1.00 1.00 
1986-1997 0.96 (0.64-1.45) 0.72 (0.53-0.97) 0.80 (0.60-1.08) 1.13 (0.85-1.51) 1.30 (0.97-1.74) 
1999-2009 1.27 (0.80-2.02) 0.73 (0.51-1.04) 0.82 (0.59-1.15) 1.65 (1.25-2.17) 2.43 (1.83-3.23) 
      
1999/2001 1.00 1.00 1.00 1.00 1.00 
2003/2005 0.84 (0.56-1.25) 0.69 (0.50-0.96) 0.68 (0.48-0.97) 0.84 (0.60-1.17) 0.96 (0.67-1.35) 
2007/2009 0.71 (0.46-1.08 ) 0.62 (0.44-0.86) 0.62 (0.47-0.83) 0.89 (0.70-1.15) 1.13 (0.86-1.48) 
OR: odds ratios (OR); CI: confidence intervals  
*Adjusted for age, sex, race, marital status, and comorbid conditions (angina, diabetes, heart failure, hypertension, and stroke).  
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† Adjusted for sociodemographics, comorbid conditions, AMI type, in-hospital clinical complications (atrial fibrillation, heart 
failure, cardiogenic shock), and hospital length of stay.  
‡ Adjusted for sociodemographics, comorbid conditions, in-hospital factors, and in-hospital management as represented by 
thrombolytic therapy and receipt of 3 coronary interventional procedures (cardiac catheterization, PCI, and CABG).  
§Adjusted for sociodemographics, comorbid conditions, in-hospital factors, in-hospital management, and prescribing of 4 
guideline-recommended cardiac medications (ACE-I/ARBs, lipid lowering agents, beta blockers, and aspirin) at the time of 
hospital discharge. 
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Figure 4-1 In-hospital clinical complications among patients who survived a first 
acute myocardial infarction (AMI): Worcester Heart Attack Study, 1975-2009 
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Figure 4-2 In-hospital coronary procedures and thrombolytic therapy, and cardiac 
medications at the time of hospital discharge among patients who survived a first 
acute myocardial infarction (AMI): Worcester Heart Attack Study, 1975-2009  
 
(a) In-hospital coronary procedures and thrombolytic therapy  
 
 
 
 
 
 
 
 
  116 
 
 
 (b) Cardiac medications at hospital discharge 
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CHAPTER 5 : CONCLUSIONS 
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 5.1 Summary of Findings 
The objectives of this dissertation were to examine changing trends in the extent 
of delay in the receipt of a primary PCI among patients who were hospitalized with 
STEMI, 30-day hospital readmission rates among patients who were  hospitalized  for 
AMI, and 1-year post-hospital mortality rates among patients who survived their 
hospitalization for a first AMI, and factors associated with these outcomes, among 
patients hospitalized with AMI at all or select medical centers in central Massachusetts 
(MA) over a multi-decade long period. 
In my first study aim, the primary objective was to describe decade-long (1999-
2009) trends in the extent of delay from hospital emergency department presentation to 
initiation of a primary PCI among patients hospitalized with STEMI. The secondary 
objective was to examine factors associated with the failure to receive a primary PCI 
within 90 minutes of hospital arrival among patients hospitalized with STEMI. The 
results suggested that, among greater Worcester residents who were hospitalized for 
STEMI and received a primary PCI at the 3 PCI-capable hospitals in central MA between 
1999 and 2009, there was a nearly 6 fold increase in the proportion of patients who 
received a timely primary PCI during the years under study. Older age, having previously 
diagnosed diabetes and chronic kidney disease, prior CABG surgery, and arriving at the 
emergency department by car/walked-in and during off-hours were significantly 
associated with a higher risk of failing to receive a primary PCI within 90 minutes of 
hospital arrival. 
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In my second study aim, the primary objective was to describe relatively 
contemporary decade long (1999-2009) trends in the frequency of 30-day all-cause and 
cause specific rehospitalizations among patients surviving hospitalization for an AMI. 
The secondary objective was to examine patient characteristics, treatment practices, and 
clinical factors associated with an increased risk of 30-day rehospitalizations among 
residents of central MA discharged from the 3 principal medical centers in central MA 
after an AMI. The results suggested that, among greater Worcester residents who 
survived their hospitalization for an AMI at the 3 major medical centers in central MA 
between 1999 and 2009, nearly 1 in 5 patients remained at risk for being rehospitalized 
within 30 days and 38% of all 30-day rehospitalizations occurred during the first week 
after hospital discharge during the years under study. The overall cause-specific 30-day 
rehospitalization rates due to CVD, non-CVD, and AMI were 10.1%, 7.1%, and 1.8%, 
respectively, during the years under study. Our findings suggested a slight decline in the 
odds of being rehospitalized during the first 30 days after hospital discharge over time 
though this odds was slightly attenuated after further adjustment for hospital treatment 
practices. In addition, we identified several demographic and clinical factors associated 
with an increased odds for being rehospitalized during the first month after hospital 
discharge for AMI that included female sex, having previously diagnosed diabetes and 
chronic kidney disease, development of heart failure during the patient’s index hospital 
admission, and having developed a STEMI during their index admission. 
In my third study aim, the primary objective was to examine changing trends in 
long-term prognosis among residents of central MA discharged from all 16 central MA 
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medical centers after a first AMI over an approximate 35-year period (1975-2009). A 
secondary study goal was to understand whether, and to what extent, increases in the use 
of effective cardiac treatment approaches during the patient’s index hospitalization were 
associated with changes in long-term mortality. Our findings suggested that there have 
been considerable changes in the demographic, clinical, and treatment profile of greater 
Worcester residents who survived their hospitalization for a first AMI at all central MA 
medical centers between 1975 and 2009. The hospital use of invasive coronary 
interventions and effective cardiac medications increased markedly over time. The 
average post-discharge 1-year all-cause mortality rates remained relatively stable from 
1975-1984 to 1986-1997, but increased slightly during 1999-2009. Using multivariable-
adjusted regression analyses, after adjustment for demographic characteristics, clinical 
factors, and in-hospital complications, no significant differences in the odds of dying 
during the first year after hospital discharge were observed during the years under study. 
Once we adjusted for the receipt of various hospital treatment practices during 
hospitalization, however, the odds of dying at 1 year post discharge among patients 
hospitalized during the most recent years under study actually increased, suggesting the 
beneficial impact of these treatment modalities on the long-term prognosis of discharged 
patients. 
 
5.2 Study Strengths and Limitations 
Several strengths of this dissertation are worth noting. We used data from a large, 
federally funded,  population-based investigation among adult residents of the Worcester, 
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MA, metropolitan area hospitalized with a confirmed AMI at all medical centers in 
central MA (Worcester Heart Attack Study: WHAS).12–15 In addition, we examined 
multi-decade long and contemporary trends in patient characteristics, treatment practices, 
as well as short and long-term outcomes in patients hospitalized with AMI.  Several 
limitations need to be acknowledged, however, in the interpretation of the present 
findings. Since our study population included only patients who had been hospitalized at 
all or selected hospitals in central MA, one needs to be careful in extrapolating our 
findings to those who died before hospitalization, or to those who reside in other 
geographic areas of the U.S. Because study patients were predominantly white, the 
generalizability of our findings to other race/ethnic groups may be limited. If a 
rehospitalization occurred outside of the Worcester metropolitan area, it was not 
captured. Our study examined pharmacotherapies prescribed at the time of hospital 
discharge. However, patients might have been prescribed these medications as 
outpatients. There is also the potential for unmeasured confounding in our observed 
associations since we did not have information available on several patient-associated 
characteristics, such as income, education, psychosocial factors, and treatment 
preference, as well as healthcare system level factors, which may have affected the 
outcomes examined. We were unable to collect information on other factors that have 
been shown to affect readmission or long-term prognosis after AMI, such as the severity 
of the AMI, transitions of care, and patients’ adherence to various post-discharge 
treatment regimens. 
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5.3 Study Implications and Future Research Directions 
Our results demonstrated a dramatic increase in the proportion of STEMI patients 
who received a primary PCI within the guideline-recommended 90 minutes after hospital 
arrival, particularly in 2007/2009, which was consistent with national efforts to reduce 
door-to-balloon times among patients hospitalized with STEMI and prior research results. 
We found that patients with STEMI admitted to the emergency department during off-
hours were more likely to fail to receive a timely primary PCI, compared with those 
admitted during regular hours. Approaches to provide onsite staffing of the cardiac 
catheterization laboratory and rapid access to interventional cardiologists during off-
hours, including consideration of the costs of providing such coverage, would be 
beneficial. Although several studies, including our current investigation, have suggested 
encouraging findings in reducing door-to-balloon times over the years, reducing door-to-
balloon time remains important in the care of patients hospitalized with STEMI. 
Healthcare providers should continue their efforts to educate patients about the symptoms 
of AMI and importance of  calling 911 to facilitate EMS triage, treatment, and hospital 
transport to reduce not only in-hospital but also prehospital treatment delays.  
Between 1999 and 2009, we found that nearly 1 in 5 patients who survived an 
AMI remained at risk for being rehospitalized within 30 days after hospital discharge, 
and 38% of all 30-day rehospitalizations occurred during the first week after hospital 
discharge. These findings suggest that proper arrangement of transitional care, and 
continuing follow up with patients during the first several days to first week post hospital 
discharge could be beneficial in reducing 30-day readmission rates among these patients. 
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In addition, we observed that a significant proportion (37%) of all 30-day hospital 
readmissions were non-CVD related. As the prevalence of comorbid conditions and aging 
of the American population increase over time, and efforts continue to be focused on the 
enhanced use of effective secondary prevention strategies to improve the post-discharge 
outcomes of patients with AMI, 30-day rehospitalizations after AMI due to non-CVD 
causes need further attention. Further research is needed to look into the “post-
hospitalization syndrome,” 70 and confirm the association between this syndrome and 
other hospital and post-discharge factors that may place patients at risk for non-CVD 
related hospital readmissions, and develop effective strategies for reducing readmissions 
due to these factors. Since our study population consisted of patients hospitalized for 
AMI between 1999 and 2009, future studies remain warranted to evaluate  possible 
changes in 30-day rehospitalization rates after the public reporting of 30-day risk-
standardized readmission rates in 2009 and the implementation of financial penalties to 
hospitals due to excess readmissions in 2012.9,29 
Our current investigation showed that the 1-year all-cause mortality  rate among 
central MA residents discharged from all area medical centers  after a first AMI remains 
relatively high, emphasizing the need for continued surveillance and optimization of the 
medical care of these patients. We also observed that the unadjusted 1-year mortality 
rates among patients discharged after a first AMI have actually increased in the most 
recently hospitalized patient cohort (1999-2009), which likely reflects the increasingly 
older patient population with a greater prevalence of multiple comorbidities. These 
findings suggest that improving the long-term outcomes of patients discharged from the 
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hospital after a first AMI will likely require expanding the use of existing, and novel, 
preventive and/or therapeutic strategies in these patients after hospital discharge, and 
these treatment plans need to take into account the age and presence of other comorbid 
conditions in these patients. To effectively implement these strategies, collaboration of 
care management between patients and their providers, and strong partnership between 
cardiologists and primary care physicians, remain crucial to the success of effective post-
discharge care transitions. Future studies examining the increasing use of conventional 
and more novel treatment strategies, and post-discharge transitions of care, in higher-risk 
patients, including the elderly and those with multiple comorbid conditions, remain 
needed to achieve greater declines in long-term mortality in this patient population. 
In conclusion, the findings of this dissertation provide useful and contemporary 
information regarding changing trends in the extent of delay in the receipt of a primary 
PCI, 30-day hospital readmission rates, and 1-year post-hospital mortality, as well as 
factors associated with these outcomes, among patients hospitalized with AMI in the 
Worcester metropolitan area. These data can hopefully lead to better development of 
innovative, patient-centered, intervention strategies which can further improve the short 
and long-term prognosis of men and women hospitalized with AMI. 
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